LNS1LawrenceShulmanLawrence Nathan Shulman, M.D.42.33789600000000-71.1072493000000012575Shulman, LawrenceNathan617/632-2277Lecturer on Global Health and Social Medicine, Part-timecatalyst:advisorInMentoringCompletedStudentProjectcompleted student projectscatalyst:eCommonsLogineCommons LoginMentoring - Completed Student Projectprns:coAuthorOfcoauthor ofprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:address2address line 2vivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:overviewoverviewvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 1023356Authorship 10464852Authorship 10452614Authorship 10468941Authorship 10467541Authorship 1049708229447501Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JVJournal of oncology practicePrinciples of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 1 of 2. J Oncol Pract. 2008 Jul; 4(4):203-206.J Oncol Pract2008-07-01T00:00:002008Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 1 of 2.29452528Shulman LN, Miller RS, Ambinder EP, Yu PP, Cox JVJournal of oncology practicePrinciples of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2. J Oncol Pract. 2008 Sep; 4(5):254-257.J Oncol Pract2008-09-01T00:00:002008Principles of Safe Practice Using an Oncology EHR System for Chemotherapy Ordering, Preparation, and Administration, Part 2 of 2.29485133Fadelu T, Shulman LNNature reviews. Clinical oncologyHealth policy: Towards greater equity in the global oncology workforce. Nat Rev Clin Oncol. 2018 05; 15(5):270-272.Nat Rev Clin Oncol2018-02-27T00:00:002018Health policy: Towards greater equity in the global oncology workforce.29412880Martei YM, Pace LE, Brock JE, Shulman LNClinics in laboratory medicineBreast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge. Clin Lab Med. 2018 03; 38(1):161-173.Clin Lab Med2017-12-13T00:00:002017Breast Cancer in Low- and Middle-Income Countries: Why We Need Pathology Capability to Solve This Challenge.29436302Vapiwala N, Shulman LN, Thomas CRJournal of oncology practiceCare Provider or Service Provider: What Should the Role of Radiation Oncologists Be in the Future? J Oncol Pract. 2018 02; 14(2):81-83.J Oncol Pract2018-02-01T00:00:002018Care Provider or Service Provider: What Should the Role of Radiation Oncologists Be in the Future?Shulman LN, Cady B, Kopans DB, Oratz R.Medical CrossfireMammography screening for breast cancer: The data behind the debate. Medical Crossfire. 2002; 4:34-45.2002-01-01T00:00:002002Mammography screening for breast cancer: The data behind the debateAuthorship 1052559229516361De La Cruz LM, Shulman LNAnnals of surgical oncology'Under' Surveillance: Impact of Race and Socioeconomic Status on Post-Treatment Breast Cancer Imaging. Ann Surg Oncol. 2018 06; 25(6):1456-1457.Ann Surg Oncol2018-03-07T00:00:002018'Under' Surveillance: Impact of Race and Socioeconomic Status on Post-Treatment Breast Cancer Imaging.Shaffer K, Smith D, Kirn D, Kaplan W, Canellos G, Mauch P, Shulman LN.Am J RoentgenolPrimary mediastinal Large B-cell lymphoma: Radiologic findings at presentation. Am J Roentgenol. 1996; 167:425-30.1996-01-01T00:00:001996Primary mediastinal Large B-cell lymphoma: Radiologic findings at presentation7570914Benjamin RJ, Linsley L, Axelrod JD, Churchill WH, Sieff C, Shulman LN, Elias A, Ayash L, Malachowski ME, Uhl LTransfusionThe collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support. Transfusion. 1995 Oct; 35(10):837-44.Transfusion1995-10-01T00:00:001995The collection and evaluation of peripheral blood progenitor cells sufficient for repetitive cycles of high-dose chemotherapy support.8947716Teich JM, Schmiz JL, O'Connell EM, Fanikos J, Marks PW, Shulman LNProceedings : a conference of the American Medical Informatics Association. AMIA Fall SymposiumAn information system to improve the safety and efficiency of chemotherapy ordering. Proc AMIA Annu Fall Symp. 1996; 498-502.Proc AMIA Annu Fall Symp1996-01-01T00:00:001996An information system to improve the safety and efficiency of chemotherapy ordering.Authorship 1027771Authorship 114298322656884Knaul FM, Shulman LN, Gralow J, Quick J, Bhadelia A, Frenk JLancet (London, England)Improving pathology for better cancer care and control in countries of low and middle income. Lancet. 2012 Jun 02; 379(9831):2052.Lancet2012-06-02T00:00:002012Improving pathology for better cancer care and control in countries of low and middle income.Shulman LN.Braunwald E, Rose BD, eds. Intensive review of internal medicineWhite blood cell disorders. Braunwald E, Rose BD, eds. Intensive review of internal medicine. 1993; 32-46.1993-01-01T00:00:001993White blood cell disorders21358956Bunnell CA, Weingart SN, Swanson S, Mamon HJ, Shulman LNJournal of oncology practiceModels of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center. J Oncol Pract. 2010 Nov; 6(6):283-8.J Oncol Pract2010-11-01T00:00:002010Models of multidisciplinary cancer care: physician and patient perceptions in a comprehensive cancer center.Authorship 1070848729866062Dusengimana JMV, Hategekimana V, Borg R, Hedt-Gauthier B, Gupta N, Troyan S, Shulman LN, Nzayisenga I, Fadelu T, Mpunga T, Pace LEBMC cancerPregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence. BMC Cancer. 2018 Jun 05; 18(1):634.BMC Cancer2018-06-05T00:00:002018Pregnancy-associated breast cancer in rural Rwanda: the experience of the Butaro Cancer Center of Excellence.Kirn D, Mauch P, Shaffer K, Pinkus G, Shipp MA, Kaplan WD, Tung N, Wheeler C, Beard CJ, Canellos GP, Shulman LN.J Clin OncolLarge cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patients. J Clin Oncol. 1993; 11:1336-43.1993-01-01T00:00:001993Large cell and immunoblastic lymphoma of the mediastinum: Prognostic features and treatment outcome in 57 patientsRamaswamy S, Osteen RT, Shulman LN.Lenhard Jr RE, Osteen RT, Gansler T, eds. The American Cancer Society's Clinical Oncology.Metastatic cancer from an unknown primary site. Lenhard Jr RE, Osteen RT, Gansler T, eds. The American Cancer Society's Clinical Oncology. 2000; 711-9.2000-01-01T00:00:002000Metastatic cancer from an unknown primary siteAuthorship 10723841229896450Tapela NM, Peluso MJ, Kohler RE, Setlhako II, Botebele K, Gabegwe K, Nkele I, Narasimhamurthy M, Mmalane M, Grover S, Barak T, Shulman LN, Lockman S, Dryden-Peterson SFrontiers in oncologyA Step Toward Timely Referral and Early Diagnosis of Cancer: Implementation and Impact on Knowledge of a Primary Care-Based Training Program in Botswana. Front Oncol. 2018; 8:187.Front Oncol2018-05-29T00:00:002018A Step Toward Timely Referral and Early Diagnosis of Cancer: Implementation and Impact on Knowledge of a Primary Care-Based Training Program in Botswana.23274388Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJJournal of the National Cancer InstituteTumor boards and the quality of cancer care. J Natl Cancer Inst. 2013 Jan 16; 105(2):113-21.J Natl Cancer Inst2012-12-28T00:00:002012Tumor boards and the quality of cancer care.Kaye JA, Shulman LNHMO PracticeScreening program for colorectal cancer: Effect on stage distribution. HMO Practice. 1992; 6:13-5.1992-01-01T00:00:001992Screening program for colorectal cancer: Effect on stage distribution2327424Mitus AJ, Barbui T, Shulman LN, Rosenthal DS, Viero P, Cortelazzo S, Schafer AIThe American journal of medicineHemostatic complications in young patients with essential thrombocythemia. Am J Med. 1990 Apr; 88(4):371-5.Am J Med1990-04-01T00:00:001990Hemostatic complications in young patients with essential thrombocythemia.6206498Raziuddin A, Sarkar FH, Dutkowski R, Shulman L, Ruddle FH, Gupta SLProceedings of the National Academy of Sciences of the United States of AmericaReceptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21. Proc Natl Acad Sci U S A. 1984 Sep; 81(17):5504-8.Proc Natl Acad Sci U S A1984-09-01T00:00:001984Receptors for human alpha and beta interferon but not for gamma interferon are specified by human chromosome 21.8541386Shulman LN, Mauch PMCurrent opinion in oncologyCurrent role of radiotherapy in Hodgkin's and non-Hodgkin's lymphoma. Curr Opin Oncol. 1995 Sep; 7(5):421-5.Curr Opin Oncol1995-09-01T00:00:001995Current role of radiotherapy in Hodgkin's and non-Hodgkin's lymphoma.22393093Landrum MB, Keating NL, Lamont EB, Bozeman SR, Krasnow SH, Shulman L, Brown JR, Earle CC, Rabin M, McNeil BJJournal of clinical oncology : official journal of the American Society of Clinical OncologySurvival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol. 2012 Apr 01; 30(10):1072-9.J Clin Oncol2012-03-05T00:00:002012Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.22910938Kahn MJ, Ma AD, Shulman LNAnnals of internal medicineUpdate in hematology and medical oncology: evidence published in 2011. Ann Intern Med. 2012 Aug 21; 157(4):276-83.Ann Intern Med2012-08-21T00:00:002012Update in hematology and medical oncology: evidence published in 2011.Antin JH, Shulman LN, editors. Hematol Oncol Clin North AmTherapy related second malignancies. Hematol Oncol Clin North Am. 1993.1993-01-01T00:00:001993Therapy related second malignanciesShulman LN.Am J Oncol RevLessons learned from the MD Anderson adjuvant trials exploring sequential chemotherapy. Am J Oncol Rev. 2003; 2:454-5.2003-01-01T00:00:002003Lessons learned from the MD Anderson adjuvant trials exploring sequential chemotherapy18021484Tolaney SM, Colson YL, Gill RR, Schulte S, Duggan MM, Shulman LN, Winer EPClinical breast cancerSarcoidosis mimicking metastatic breast cancer. Clin Breast Cancer. 2007 Oct; 7(10):804-10.Clin Breast Cancer2007-10-01T00:00:002007Sarcoidosis mimicking metastatic breast cancer.Authorship 109630622548004Weingart SN, Li JW, Zhu J, Morway L, Stuver SO, Shulman LN, Hassett MJJournal of oncology practiceUS Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards. J Oncol Pract. 2012 Jan; 8(1):7-12.J Oncol Pract2011-12-06T00:00:002011US Cancer Center Implementation of ASCO/Oncology Nursing Society Chemotherapy Administration Safety Standards.22843789Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DLClinical cancer research : an official journal of the American Association for Cancer ResearchA genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012 Sep 15; 18(18):5099-109.Clin Cancer Res2012-07-27T00:00:002012A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.Shulman LN, Zukerberg LR.N Engl J MedCase records of the Massachusetts General Hospital. N Engl J Med. 1990; 322(1585):94.1990-01-01T00:00:001990Case records of the Massachusetts General Hospital8387871Lynch TJ, Kass F, Kalish LA, Elias AD, Strauss G, Shulman LN, Sugarbaker DJ, Skarin A, Frei ECancerCisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer. Cancer. 1993 May 15; 71(10):2953-7.Cancer1993-05-15T00:00:001993Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer.8468270Kelsey KT, Caggana-Aviles M, Mauch P, Coleman CN, Shulman LN, Liber HLHematology/oncology clinics of North AmericaMutagenesis after therapy for Hodgkin's disease. Hematol Oncol Clin North Am. 1993 Apr; 7(2):353-67.Hematol Oncol Clin North Am1993-04-01T00:00:001993Mutagenesis after therapy for Hodgkin's disease.Authorship 1087502430084718Garcia-Gonzalez P, Lopes G, Schwartz E, Shulman LNJournal of global oncologyThe Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines. J Glob Oncol. 2018 07; 4:1-3.J Glob Oncol2018-07-01T00:00:002018The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines.8478226Uematsu M, Bornstein BA, Recht A, Abner A, Come SE, Shulman LN, Silver B, Harris JRInternational journal of radiation oncology, biology, physicsLong-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer. Int J Radiat Oncol Biol Phys. 1993 Apr 02; 25(5):765-70.Int J Radiat Oncol Biol Phys1993-04-02T00:00:001993Long-term results of post-operative radiation therapy following mastectomy with or without chemotherapy in stage I-III breast cancer.20856635Buswell LA, Ponte PR, Shulman LNJournal of oncology practiceProvider practice models in ambulatory oncology practice: analysis of productivity, revenue, and provider and patient satisfaction. J Oncol Pract. 2009 Jul; 5(4):188-92.J Oncol Pract2009-07-01T00:00:002009Provider practice models in ambulatory oncology practice: analysis of productivity, revenue, and provider and patient satisfaction.894109Shulman LN, Robinson SHThe Journal of laboratory and clinical medicineMaintenance of hemopoietic stem cells in diffusion chamber cultures. J Lab Clin Med. 1977 Sep; 90(3):581-8.J Lab Clin Med1977-09-01T00:00:001977Maintenance of hemopoietic stem cells in diffusion chamber cultures.8005814Shulman LN, Buswell L, Goodman H, Muto M, Berkowitz R, Teicher B, Kusumoto T, Hurwitz SJ, Kalish LA, Coleman CNInternational journal of radiation oncology, biology, physicsPhase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):545-8.Int J Radiat Oncol Biol Phys1994-06-15T00:00:001994Phase I pharmacokinetic study of the hypoxic cell sensitizer etanidazole with carboplatin and cyclophosphamide in the treatment of advanced ovarian cancer.8313319Lynch TJ, Kalish LA, Kass F, Strauss G, Elias A, Skarin A, Shulman L, Sugarbaker D, Frei ECancerContinuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer. Cancer. 1994 Feb 15; 73(4):1171-6.Cancer1994-02-15T00:00:001994Continuous-infusion cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.Authorship 1207584Authorship 104855219387748Weingart SN, Saadeh MG, Simchowitz B, Gandhi TK, Nekhlyudov L, Studdert DM, Puopolo AL, Shulman LNJournal of general internal medicineProcess of care failures in breast cancer diagnosis. J Gen Intern Med. 2009 Jun; 24(6):702-9.J Gen Intern Med2009-04-23T00:00:002009Process of care failures in breast cancer diagnosis.20410447Drews RE, Shulman LNAnnals of internal medicineUpdate in hematology and oncology. Ann Intern Med. 2010 May 18; 152(10):655-62.Ann Intern Med2010-04-21T00:00:002010Update in hematology and oncology.Authorship 10928585Authorship 109432915Authorship 109261317Authorship 10929967Authorship 109441710Authorship 109380510Authorship 10934826Authorship 1093510730241207O'Neil DS, Keating NL, Dusengimana JMV, Hategekimana V, Umwizera A, Mpunga T, Shulman LN, Pace LEJournal of global oncologyQuality of Breast Cancer Treatment at a Rural Cancer Center in Rwanda. J Glob Oncol. 2018 09; 4:1-11.J Glob Oncol2017-05-12T00:00:002017Quality of Breast Cancer Treatment at a Rural Cancer Center in Rwanda.30241228Pace LE, Dusengimana JV, Keating NL, Hategekimana V, Rugema V, Bigirimana JB, Costas-Chavarri A, Umwizera A, Park PH, Shulman LN, Mpunga TJournal of global oncologyImpact of Breast Cancer Early Detection Training on Rwandan Health Workers' Knowledge and Skills. J Glob Oncol. 2018 09; 4:1-10.J Glob Oncol2018-09-01T00:00:002018Impact of Breast Cancer Early Detection Training on Rwandan Health Workers' Knowledge and Skills.30241225Martei YM, Chiyapo S, Grover S, Ramogola-Masire D, Dryden-Peterson S, Shulman LN, Tapela NJournal of global oncologyAvailability of WHO Essential Medicines for Cancer Treatment in Botswana. J Glob Oncol. 2018 09; 4:1-8.J Glob Oncol2018-09-01T00:00:002018Availability of WHO Essential Medicines for Cancer Treatment in Botswana.30241136Muvugabigwi G, Nshimiyimana I, Greenberg L, Hakizimana E, Ruhangaza D, Benewe O, Bhai K, Pepoon JR, Fehr AE, Park PH, Butonzi J, Shyirambere C, Manirakiza A, Rusangwa C, Milner D, Mpunga T, Shulman LNJournal of global oncologyDecreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda. J Glob Oncol. 2018 09; 4:1-6.J Glob Oncol2017-11-16T00:00:002017Decreasing Histology Turnaround Time Through Stepwise Innovation and Capacity Building in Rwanda.30241148Rubagumya F, Xu MJ, May L, Driscoll C, Uwizeye FR, Shyirambere C, Larrabee K, Fehr AE, Gilbert UD, Muhayimana C, Hategekimana V, Elmore S, Mpunga T, Moore M, Shulman LN, Lehmann LJournal of global oncologyOutcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 09; 4:1-11.J Glob Oncol2017-10-30T00:00:002017Outcomes of Low-Intensity Treatment of Acute Lymphoblastic Leukemia at Butaro Cancer Center of Excellence in Rwanda.30241219Neal C, Rusangwa C, Borg R, Tapela N, Mugunga JC, Pritchett N, Shyirambere C, Ntakirutimana E, Park PH, Shulman LN, Mpunga TJournal of global oncologyCost of Providing Quality Cancer Care at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 09; 4:1-7.J Glob Oncol2017-07-17T00:00:002017Cost of Providing Quality Cancer Care at the Butaro Cancer Center of Excellence in Rwanda.30241244Martei YM, Chiyapo S, Grover S, Hanna C, Dryden-Peterson S, Pusoentsi M, Shulman LN, Tapela NJournal of global oncologyMethodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries. J Glob Oncol. 2018 09; 4:1-8.J Glob Oncol2018-09-01T00:00:002018Methodology to Forecast Volume and Cost of Cancer Drugs in Low- and Middle-Income Countries.30241187Hortobagyi GN, Pyle D, Cazap EL, El Saghir NS, Shulman LN, Lyman GH, Schnipper LE, Adebamowo CA, Gandara DR, Vose J, Wong SL, Yu PJournal of global oncologyAmerican Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions. J Glob Oncol. 2018 09; 4:1-8.J Glob Oncol2017-08-11T00:00:002017American Society of Clinical Oncology's Global Oncology Leadership Task Force: Findings and Actions.23071233Miriovsky BJ, Shulman LN, Abernethy APJournal of clinical oncology : official journal of the American Society of Clinical OncologyImportance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care. J Clin Oncol. 2012 Dec 01; 30(34):4243-8.J Clin Oncol2012-10-15T00:00:002012Importance of health information technology, electronic health records, and continuously aggregating data to comparative effectiveness research and learning health care.Shulman LN, Sugarbaker DJ.Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast.Malignant effusions. Harris JR, Lippman ME, Morrow M, Hellman S, eds. Diseases of the breast. 1995; 833-40.1995-01-01T00:00:001995Malignant effusionsNadler E, Shulman LN.Am J Oncol RevHigh-dose, stem cell supported chemotherapy vs conventional chemotherapy as treatment for patients with locally advanced breast cancer: Do randomized trials settle the debate?. Am J Oncol Rev. 2004; 3:36-38.2004-01-01T00:00:002004High-dose, stem cell supported chemotherapy vs conventional chemotherapy as treatment for patients with locally advanced breast cancer: Do randomized trials settle the debate?Shulman LN, Lichter AS, Allison MA, Bitran JD, Davidson NE, Grunberg SM, Halberg FE, Lewis BJ, Link MP, Mazanet R, Offit K, Ozer H, Presant CA, Runowicz CD, Seardino PT, Schnipper LE, Stovall EL, Vogelzang NJ, Wade JL, Weber BL, Wiernik PH.J Clin OncolAmerican Society of Clinical Oncology. Special Article: Funding for clinical (patient-oriented) oncology research: Current status and recommendations for improvement. J Clin Oncol. 1996; 14:666-70.1996-01-01T00:00:001996American Society of Clinical Oncology. Special Article: Funding for clinical (patient-oriented) oncology research: Current status and recommendations for improvementShulman LN, Cutler CS.Carlson K, Eisenstat SA, eds. Primary care of women.Non-gynecologic cancer in pregnancy. Carlson K, Eisenstat SA, eds. Primary care of women. 2002; 540-5.2002-01-01T00:00:002002Non-gynecologic cancer in pregnancy8523055Shipp MA, Neuberg D, Janicek M, Canellos GP, Shulman LNJournal of clinical oncology : official journal of the American Society of Clinical OncologyHigh-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. J Clin Oncol. 1995 Dec; 13(12):2916-23.J Clin Oncol1995-12-01T00:00:001995High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.Authorship 11064144Authorship 11008586Authorship 11035636Authorship 11051881326621151Vargas SE, Fava JL, Severy L, Rosen RK, Salomon L, Shulman L, Guthrie KMArchives of sexual behaviorPsychometric Properties and Validity of a Multi-dimensional Risk Perception Scale Developed in the Context of a Microbicide Acceptability Study. Arch Sex Behav. 2016 Feb; 45(2):415-28.Arch Sex Behav2015-11-30T00:00:002015Psychometric Properties and Validity of a Multi-dimensional Risk Perception Scale Developed in the Context of a Microbicide Acceptability Study.19659761Toruner GA, Kurvathi R, Sugalski R, Shulman L, Twersky S, Pearson PG, Tozzi R, Schwalb MN, Wallerstein RClinical geneticsCopy number variations in three children with sudden infant death. Clin Genet. 2009 Jul; 76(1):63-8.Clin Genet2009-07-01T00:00:002009Copy number variations in three children with sudden infant death.30321096Hanappe M, Nicholson LT, Elmore SNC, Fehr AE, Bigirimana JB, Borg RC, Butonzi J, Shyirambere C, Mpanumusingo E, Benewe MO, Kanyike DM, Triedman S, Shulman LN, Rusangwa C, Park PHJournal of global oncologyInternational Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical Outcomes. J Glob Oncol. 2018 10; 4:1-12.J Glob Oncol2018-10-01T00:00:002018International Radiotherapy Referrals From Rural Rwanda: Implementation Processes and Early Clinical Outcomes.17333312Morrow KM, Vargas S, Rosen RK, Christensen AL, Salomon L, Shulman L, Barroso C, Fava JLAIDS and behaviorThe utility of non-proportional quota sampling for recruiting at-risk women for microbicide research. AIDS Behav. 2007 Jul; 11(4):586-95.AIDS Behav2007-02-27T00:00:002007The utility of non-proportional quota sampling for recruiting at-risk women for microbicide research.9369141Wong JS, Recht A, Beard CJ, Busse PM, Cady B, Chaffey JT, Come S, Fam S, Kaelin C, Lingos TI, Nixon AJ, Shulman LN, Troyan S, Silver B, Harris JRInternational journal of radiation oncology, biology, physicsTreatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys. 1997 Nov 01; 39(4):915-20.Int J Radiat Oncol Biol Phys1997-11-01T00:00:001997Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes.8418240Abner AL, Recht A, Eberlein T, Come S, Shulman L, Hayes D, Connolly JL, Schnitt SJ, Silver B, Harris JRJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol. 1993 Jan; 11(1):44-8.J Clin Oncol1993-01-01T00:00:001993Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer.Authorship 10562620856750Shulman LN, Jacobs LA, Greenfield S, Jones B, McCabe MS, Syrjala K, Diller L, Shapiro CL, Marcus AC, Campbell M, Santacroce S, Kagawa-Singer M, Ganz PAJournal of oncology practiceCancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? J Oncol Pract. 2009 May; 5(3):119-23.J Oncol Pract2009-05-01T00:00:002009Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future?Authorship 1109513830380140Martin AN, Silverstein A, Ssebuufu R, Lule J, Mugenzi P, Fehr A, Mpunga T, Shulman LN, Park PH, Costas-Chavarri AJournal of surgical oncologyImpact of delayed care on surgical management of patients with gastric cancer in a low-resource setting. J Surg Oncol. 2018 Dec; 118(8):1237-1242.J Surg Oncol2018-10-31T00:00:002018Impact of delayed care on surgical management of patients with gastric cancer in a low-resource setting.Authorship 11106271230409792Barginear M, Dueck AC, Allred JB, Bunnell C, Cohen HJ, Freedman RA, Hurria A, Kimmick G, Le-Rademacher JG, Lichtman S, Muss HB, Shulman LN, Copur MS, Biggs D, Ramaswamy B, Lafky JM, Jatoi AThe oncologistAge and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101. Oncologist. 2019 05; 24(5):617-623.Oncologist2018-11-08T00:00:002018Age and the Risk of Paclitaxel-Induced Neuropathy in Women with Early-Stage Breast Cancer (Alliance A151411): Results from 1,881 Patients from Cancer and Leukemia Group B (CALGB) 40101.Hassett MJ, Shulman LN.Am J Oncol RevDose-dense chemotherapy as adjuvant therapy for node-positive breast cancer: Does this work and why?. Am J Oncol Rev. 2003; 2:378-81.2003-01-01T00:00:002003Dose-dense chemotherapy as adjuvant therapy for node-positive breast cancer: Does this work and why?Kaye JA, Shulman LNHMO PracticeScreening program for colorectal cancer: Participation and follow-up. HMO Practice. 1991; 5:168-70.1991-01-01T00:00:001991Screening program for colorectal cancer: Participation and follow-upAuthorship 11127351230433841Neal C, Rusangwa C, Borg R, Mugunga JC, Kennell-Heiling S, Shyirambere C, Pritchett N, Muhayimana C, Ntakirutimana E, Tapela N, Park PH, Shulman LN, Mpunga TJournal of global oncologyCost of Treating Pediatric Cancer at the Butaro Cancer Center of Excellence in Rwanda. J Glob Oncol. 2018 11; 4:1-7.J Glob Oncol2018-11-01T00:00:002018Cost of Treating Pediatric Cancer at the Butaro Cancer Center of Excellence in Rwanda.16779370Pizziferri L, Kittler AF, Volk LA, Shulman LN, Kessler J, Carlson G, Michaelidis T, Bates DWAMIA ... Annual Symposium proceedings. AMIA SymposiumImpact of an Electronic Health Record on oncologists' clinic time. AMIA Annu Symp Proc. 2005; 1083.AMIA Annu Symp Proc2005-01-01T00:00:002005Impact of an Electronic Health Record on oncologists' clinic time.Authorship 144324187707123Mauch PM, Canellos GP, Shulman LN, Silver B, Tarbell NJ, Come S, Rabin MS, Coleman CNJournal of clinical oncology : official journal of the American Society of Clinical OncologyMantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial. J Clin Oncol. 1995 Apr; 13(4):947-52.J Clin Oncol1995-04-01T00:00:001995Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.Authorship 1117267630507437Velazquez Berumen A, Jimenez Moyao G, Rodriguez NM, Ilbawi AM, Migliore A, Shulman LNThe Lancet. OncologyDefining priority medical devices for cancer management: a WHO initiative. Lancet Oncol. 2018 12; 19(12):e709-e719.Lancet Oncol2018-12-01T00:00:002018Defining priority medical devices for cancer management: a WHO initiative.Authorship 125077621933890Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray RClinical cancer research : an official journal of the American Association for Cancer ResearchRelationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer. Clin Cancer Res. 2011 Nov 15; 17(22):7194-203.Clin Cancer Res2011-09-20T00:00:002011Relationship between quantitative GRB7 RNA expression and recurrence after adjuvant anthracycline chemotherapy in triple-negative breast cancer.22043188Beckjord EB, Rechis R, Nutt S, Shulman L, Hesse BWJournal of oncology practiceWhat Do People Affected by Cancer Think About Electronic Health Information Exchange? Results From the 2010 LIVESTRONG Electronic Health Information Exchange Survey and the 2008 Health Information National Trends Survey. J Oncol Pract. 2011 Jul; 7(4):237-41.J Oncol Pract2011-07-01T00:00:002011What Do People Affected by Cancer Think About Electronic Health Information Exchange? Results From the 2010 LIVESTRONG Electronic Health Information Exchange Survey and the 2008 Health Information National Trends Survey.22547108Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW, Sparano JABreast cancer research and treatmentPrognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Res Treat. 2012 Jul; 134(2):683-92.Breast Cancer Res Treat2012-05-01T00:00:002012Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RM.Ann Intern MedThe association of myelodysplastic syndrome with Crohn's disease. Ann Intern Med. 1992; 117:661-2.1992-01-01T00:00:001992The association of myelodysplastic syndrome with Crohn's diseaseShulman, LNAm J Hematol OncolMultidisciplinary breast cancer care: perspectives from team members at Dana-Farber Cancer Institute/Multidisciplinary breast cancer care from the point of view of the medical oncologist. Am J Hematol Oncol. 2007; 6:17-18.2007-01-01T00:00:002007Multidisciplinary breast cancer care: perspectives from team members at Dana-Farber Cancer Institute/Multidisciplinary breast cancer care from the point of view of the medical oncologistShulman LN, Robinson SH. Carsten AE, Cronkite EP, eds. Hemopoietic cell culture in diffusion chambers.Roles of CFU-S and CFU-C in maintaining cell growth in diffusion chamber cultures of murine marrow. Carsten AE, Cronkite EP, eds. Hemopoietic cell culture in diffusion chambers. 1980; 11-8.1980-01-01T00:00:001980Roles of CFU-S and CFU-C in maintaining cell growth in diffusion chamber cultures of murine marrowLynch TJ, Kalish LA, Kass F, Strauss G, Elias A, Skarin A, Shulman L, Sugarbaker D, Frei E.CancerContinuous infusion cisplatin, 5-FU and leucovorin (PFL) for advanced non-small cell lung cancer. Cancer. 1994; 73:1171-6.1994-01-01T00:00:001994Continuous infusion cisplatin, 5-FU and leucovorin (PFL) for advanced non-small cell lung cancerAuthorship 11219131130582433Park PH, Davey S, Fehr AE, Butonzi J, Shyirambere C, Hategekimana V, Bigirimana JB, Borg R, Uwizeye R, Tapela N, Shulman LN, Randall T, Mpanumusingo E, Mpunga TJournal of global oncologyPatient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda. J Glob Oncol. 2018 12; 4:1-11.J Glob Oncol2018-12-01T00:00:002018Patient Characteristics, Early Outcomes, and Implementation Lessons of Cervical Cancer Treatment Services in Rural Rwanda.Shulman LN, Braunwald E, Rosenthal DS.Braunwald E, ed. Heart Disease: A textbook of cardiovascular medicine.Hematologic-oncologic disorders and heart disease. Braunwald E, ed. Heart Disease: A textbook of cardiovascular medicine. 1997; 1786-1808.1997-01-01T00:00:001997Hematologic-oncologic disorders and heart disease7697983Marks PW, Shulman LNComprehensive therapyThe diagnosis and management of multiple myeloma. Compr Ther. 1995; 21(1):7-12.Compr Ther1995-01-01T00:00:001995The diagnosis and management of multiple myeloma.8387578Shulman LN, Frisard B, Antin JH, Wheeler C, Pinkus G, Magauran N, Mauch P, Nobles E, Mashal R, Canellos GJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrimary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome. J Clin Oncol. 1993 May; 11(5):937-42.J Clin Oncol1993-05-01T00:00:001993Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome.10760430Shulman LN, Buswell L, Riese N, Doherty N, Loeffler JS, von Roemeling RW, Coleman CNInternational journal of radiation oncology, biology, physicsPhase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors. Int J Radiat Oncol Biol Phys. 1999 May 01; 44(2):349-53.Int J Radiat Oncol Biol Phys1999-05-01T00:00:001999Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors.Authorship 122835719047116Burstein HJ, Chen YH, Parker LM, Savoie J, Younger J, Kuter I, Ryan PD, Garber JE, Chen H, Campos SM, Shulman LN, Harris LN, Gelman R, Winer EPClinical cancer research : an official journal of the American Association for Cancer ResearchVEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy. Clin Cancer Res. 2008 Dec 01; 14(23):7871-7.Clin Cancer Res2008-12-01T00:00:002008VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelbine chemotherapy.23204130Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, Owzar K, Jiang C, Watson D, Shterev I, Kubo M, Zembutsu H, Winer EP, Hudis CA, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL, Cox NJ, Dolan MEClinical cancer research : an official journal of the American Association for Cancer ResearchIntegration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15; 19(2):491-9.Clin Cancer Res2012-11-30T00:00:002012Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.Shulman LN.Rippe JM, Irwin RS, Fink MP, Cerra FB, eds. Intensive care medicine.The acute leukemias. Rippe JM, Irwin RS, Fink MP, Cerra FB, eds. Intensive care medicine. 1996; 1432-7.1996-01-01T00:00:001996The acute leukemias8005813Shulman LN, Buswell L, Kalish LA, Coleman CNInternational journal of radiation oncology, biology, physicsUse of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: a pharmacokinetic study. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):541-3.Int J Radiat Oncol Biol Phys1994-06-15T00:00:001994Use of the hypoxic cell sensitizer etanidazole (SR-2508) with intravenous melphalan and prednisone in the treatment of multiple myeloma: a pharmacokinetic study.Authorship 11262648614420Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, Shulman LN, Harris JRThe New England journal of medicineThe sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996 May 23; 334(21):1356-61.N Engl J Med1996-05-23T00:00:001996The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer.30887125Lopez D, Pratt-Chapman ML, Rohan EA, Sheldon LK, Basen-Engquist K, Kline R, Shulman LN, Flores EJSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerEstablishing effective patient navigation programs in oncology. Support Care Cancer. 2019 Jun; 27(6):1985-1996.Support Care Cancer2019-03-18T00:00:002019Establishing effective patient navigation programs in oncology.D001943Disorders2830206760.141753Breast NeoplasmsD008495Occupations88022170.421733Medical OncologyD012432Geographic Areas1606960.798058RwandaAuthorship 11414397Authorship 11427278Authorship 11471441Authorship 11438809Authorship 1145869830927195Shulman LN, Browner AE, Palis BE, Mallin K, Kakade S, Carp N, McCabe R, Winchester D, Wong SL, McKellar DPAnnals of surgical oncologyCompliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections. Ann Surg Oncol. 2019 Jun; 26(6):1613-1621.Ann Surg Oncol2019-03-29T00:00:002019Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections.30737668Mallin K, Browner A, Palis B, Gay G, McCabe R, Nogueira L, Yabroff R, Shulman L, Facktor M, Winchester DP, Nelson HAnnals of surgical oncologyIncident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014. Ann Surg Oncol. 2019 Jun; 26(6):1604-1612.Ann Surg Oncol2019-02-08T00:00:002019Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.30969808Martei YM, Grover S, Bilker WB, Monare B, Setlhako DI, Ralefala TB, Manshimba P, Gross R, Shulman LN, DeMichele AJournal of global oncologyImpact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting. J Glob Oncol. 2019 04; 5:1-11.J Glob Oncol2019-04-01T00:00:002019Impact of Essential Medicine Stock Outs on Cancer Therapy Delivery in a Resource-Limited Setting.30975921Dao D, Zemla T, Jatoi A, Freedman RA, Hurria A, Muss H, Cohen HJ, Shulman LN, Citron M, Budman D, McMurray R, Partridge A, Carey L, Sedrak MS, Lafky JM, Le-Rademacher JGThe oncologistOlder-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715). Oncologist. 2019 06; 24(6):e284-e291.Oncologist2019-04-11T00:00:002019Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).D009369Disorders4449215070.127349NeoplasmsD002173ObjectsOrganizations2644010.783068Cancer Care FacilitiesEmeritusGlobal Health and Social MedicineHealth Care PolicyMedicinePediatricsHematology/OncologyGeneral MedicineWomen's HealthAdult OncologyOncologyHematologyDivision of Global Health EquityBrigham and Women's HospitalDana-Farber Cancer InstituteHarvard Medical SchoolAHP1AnnPartridgeAnn Hart Partridge, M.D.42.33789600000000-71.1072493000000084598Partridge, AnnProfessor of MedicineDWB3DavidBatesDavid Westfall Bates, M.D.42.33510370000000-71.10616490000000449Bates, DavidProfessor of MedicineAuthorship 1152543531095326Nekhlyudov L, Mollica MA, Jacobsen PB, Mayer DK, Shulman LN, Geiger AMJournal of the National Cancer InstituteDeveloping a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy. J Natl Cancer Inst. 2019 11 01; 111(11):1120-1130.J Natl Cancer Inst2019-11-01T00:00:002019Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research, and Policy.Authorship 1155898631119565Pomponio MK, Keele LJ, Fox KR, Clark AS, Matro JM, Shulman LN, Tchou JCBreast cancer research and treatmentDoes time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer? Breast Cancer Res Treat. 2019 Aug; 177(1):137-143.Breast Cancer Res Treat2019-05-22T00:00:002019Does time to adjuvant chemotherapy (TTC) affect outcomes in patients with triple-negative breast cancer?EJB6EdwardBenzEdward J. Benz, Jr., M.D.42.33789600000000-71.1072493000000040922Benz, EdwardRichard and Susan Smith Distinguished Professor of MedicineAuthorship 1157206631128144Vapiwala N, Thomas CR, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CNInternational journal of radiation oncology, biology, physicsEnhancing Career Paths for Tomorrow's Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):52-63.Int J Radiat Oncol Biol Phys2019-05-22T00:00:002019Enhancing Career Paths for Tomorrow's Radiation Oncologists.NLK2NancyKeatingNancy Lynn Keating, M.D.42.33610940000000-71.1008845000000017235Keating, NancyProfessor of Health Care PolicyUAM1UrsulaMatulonisUrsula Anne Matulonis, M.D.42.33789600000000-71.1072493000000087439Matulonis, UrsulaProfessor of MedicineCDS3CharlesStilesCharles Dean Stiles, Ph.D.42.33789600000000-71.1072493000000045121Stiles, CharlesProfessor of Neurobiology, EmeritusWGK1WilliamKaelinWilliam George Kaelin, M.D.42.33789600000000-71.1072493000000035158Kaelin, WilliamSidney Farber Professor of MedicineAuthorship 1162854131214848Shulman LNAnnals of surgical oncologyASO Author Reflections: Better Understanding of What We Have Learned from Cancer Care Quality Metrics. Ann Surg Oncol. 2019 12; 26(Suppl 3):641-642.Ann Surg Oncol2019-06-18T00:00:002019ASO Author Reflections: Better Understanding of What We Have Learned from Cancer Care Quality Metrics.NMT7NeoTapelaNeo Millicent Tapela, M.D.42.33510370000000-71.1061649000000046352Tapela, NeoInstructor in MedicineEPW2EricWinerEric Paul Winer, M.D.42.33789600000000-71.107249300000005538Winer, EricProfessor of Medicine, EmeritusJR11JeromeRitzJerome Ritz, M.D.42.33789600000000-71.1072493000000052061Ritz, JeromeProfessor of MedicineAAL9AndrewLaneAndrew Alan Lane, M.D.,Ph.D.42.33789600000000-71.1072493000000063478Lane, AndrewAssociate Professor of MedicineJWM4JenniferMackJennifer Williams Mack, M.D.42.33789600000000-71.1072493000000055623Mack, JenniferAssociate Professor of Pediatrics11391selected publications4.024150.00133796789research areas4.092080.00431466154coauthor of103.4432.470660similar toLEP7LydiaPaceLydia Eleanor Wiedel Pace, M.D.42.33510370000000-71.1061649000000074935Pace, LydiaAssociate Professor of MedicineAuthorship 11655642Authorship 1165601431236646Mehta SD, Weber K, Fleisher L, Shulman LN, Gabriel P, Trerotola SO, Nawas M, Chi AS, Sebro RCardiovascular and interventional radiologyAssessing the Need for Preprocedural Laboratory Tests and Stopping Non-steroidal Anti-inflammatory Drugs/Aspirin in Patients Undergoing Percutaneous Bone and Soft Tissue Biopsies. Cardiovasc Intervent Radiol. 2019 Nov; 42(11):1588-1596.Cardiovasc Intervent Radiol2019-06-24T00:00:002019Assessing the Need for Preprocedural Laboratory Tests and Stopping Non-steroidal Anti-inflammatory Drugs/Aspirin in Patients Undergoing Percutaneous Bone and Soft Tissue Biopsies.31233139Nekhlyudov L, Shulman LN, Jacobsen PB, Mollica MA, Geiger AM, Mayer DKJournal of the National Cancer InstituteResponse to Jefford. J Natl Cancer Inst. 2020 03 01; 112(3):322-323.J Natl Cancer Inst2020-03-01T00:00:002020Response to Jefford.Authorship 1385771Authorship 11828241031466858Schleimer LE, Vianney Dusengimana JM, Butonzi J, Kigonya C, Natarajan A, Umwizerwa A, O'Neil DS, Costas-Chavarri A, Majyambere JP, Shulman LN, Keating NL, Shyirambere C, Mpunga T, Pace LESurgeryBarriers to timely surgery for breast cancer in Rwanda. Surgery. 2019 12; 166(6):1188-1195.Surgery2019-08-27T00:00:002019Barriers to timely surgery for breast cancer in Rwanda.Authorship 1189644831509483Kline RM, Rocque GB, Rohan EA, Blackley KA, Cantril CA, Pratt-Chapman ML, Burris HA, Shulman LNJournal of oncology practicePatient Navigation in Cancer: The Business Case to Support Clinical Needs. J Oncol Pract. 2019 11; 15(11):585-590.J Oncol Pract2019-09-11T00:00:002019Patient Navigation in Cancer: The Business Case to Support Clinical Needs.Authorship 1516951Authorship 1199849831651973Parikh RB, Manz C, Chivers C, Regli SH, Braun J, Draugelis ME, Schuchter LM, Shulman LN, Navathe AS, Patel MS, O'Connor NRJAMA network openMachine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer. JAMA Netw Open. 2019 10 02; 2(10):e1915997.JAMA Netw Open2019-10-02T00:00:002019Machine Learning Approaches to Predict 6-Month Mortality Among Patients With Cancer.true1Professor of MedicineProfessor of Medicinetrue1Professor of Neurobiology, EmeritusProfessor of Neurobiology, Emeritustrue1Professor of MedicineProfessor of Medicinetrue1Professor of MedicineProfessor of Medicinetrue1Sidney Farber Professor of MedicineSidney Farber Professor of Medicinetrue1Instructor in MedicineInstructor in MedicineAuthorship 1207639331774713Pace LE, Dusengimana JMV, Shulman LN, Schleimer LE, Shyirambere C, Rusangwa C, Muvugabigwi G, Park PH, Huang C, Bigirimana JB, Hategekimana V, Rugema V, Umwizerwa A, Keating NL, Mpunga TJournal of global oncologyCluster Randomized Trial to Facilitate Breast Cancer Early Diagnosis in a Rural District of Rwanda. J Glob Oncol. 2019 11; 5:1-13.J Glob Oncol2019-11-01T00:00:002019Cluster Randomized Trial to Facilitate Breast Cancer Early Diagnosis in a Rural District of Rwanda.true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 1162285Authorship 1211768131858297Shulman LNAnnals of surgical oncologyDr Charlton et al., Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections". Ann Surg Oncol. 2020 04; 27(4):1308.Ann Surg Oncol2019-12-19T00:00:002019Dr Charlton et al., Commentary and Complementary Data to Add to "Compliance with Cancer Quality Measures Over Time and Their Association with Survival Outcomes: The Commission on Cancer's Experience with the Quality Measure Requiring at Least 12 Regional Lymph Nodes to be Removed and Analyzed with Colon Cancer Resections".Authorship 12132101031868912Takvorian SU, Balogh E, Nass S, Valentin VL, Hoffman-Hogg L, Oyer RA, Carlson RW, Meropol NJ, Sheldon LK, Shulman LNJournal of the National Cancer InstituteDeveloping and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action. J Natl Cancer Inst. 2020 07 01; 112(7):663-670.J Natl Cancer Inst2020-07-01T00:00:002020Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action.Authorship 1216217931919848Pomponio MK, Burkbauer L, Goldbach M, Nazarian SM, Xie F, Clark AS, Matro JM, Fox KR, Shulman LN, Keele LJ, Tchou JJournal of surgical oncologyRefining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience. J Surg Oncol. 2020 Mar; 121(3):447-455.J Surg Oncol2020-01-09T00:00:002020Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.Authorship 12207761Authorship 12204161131964523James TA, Palis B, McCabe R, Pardo JA, Alapati A, Ukandu O, Serres SK, Zhang J, Mele A, Facktor M, Shulman LNAmerican journal of surgeryEvaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery. Am J Surg. 2020 09; 220(3):654-659.Am J Surg2020-01-13T00:00:002020Evaluating the role of sentinel lymph node biopsy in patients with DCIS treated with breast conserving surgery.31971546Shulman LN, Sheldon LK, Benz EJJAMA oncologyThe Future of Cancer Care in the United States-Overcoming Workforce Capacity Limitations. JAMA Oncol. 2020 03 01; 6(3):327-328.JAMA Oncol2020-03-01T00:00:002020The Future of Cancer Care in the United States-Overcoming Workforce Capacity Limitations.Authorship 122210811Authorship 1221760931982648Manz CR, Parikh RB, Evans CN, Chivers C, Regli SH, Bekelman JE, Small D, Rareshide CAL, O'Connor N, Schuchter LM, Shulman LN, Patel MSContemporary clinical trialsIntegrating machine-generated mortality estimates and behavioral nudges to promote serious illness conversations for cancer patients: Design and methods for a stepped-wedge cluster randomized controlled trial. Contemp Clin Trials. 2020 03; 90:105951.Contemp Clin Trials2020-01-23T00:00:002020Integrating machine-generated mortality estimates and behavioral nudges to promote serious illness conversations for cancer patients: Design and methods for a stepped-wedge cluster randomized controlled trial.31988040Christodouleas JP, Anderson N, Gabriel P, Greene R, Hahn C, Kessler S, Mayo CS, McNutt T, Shulman LN, Smith BD, West J, Williamson TPractical radiation oncologyA Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report. Pract Radiat Oncol. 2020 Nov - Dec; 10(6):389-401.Pract Radiat Oncol2020-01-24T00:00:002020A Multidisciplinary Consensus Recommendation on a Synoptic Radiation Treatment Summary: A Commission on Cancer Workgroup Report.Authorship 1223109532023124El Saghir NS, Anderson BO, Gralow J, Lopes G, Shulman LN, Moukadem HA, Yu PP, Hortobagyi GJCO global oncologyImpact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries. JCO Glob Oncol. 2020 02; 6:185-189.JCO Glob Oncol2020-02-01T00:00:002020Impact of Merit-Based Immigration Policies on Brain Drain From Low- and Middle-Income Countries.Authorship 1226650532074294Takvorian SU, Oganisian A, Mamtani R, Mitra N, Shulman LN, Bekelman JE, Werner RMJAMA network openAssociation of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer. JAMA Netw Open. 2020 02 05; 3(2):e1921653.JAMA Netw Open2020-02-05T00:00:002020Association of Medicaid Expansion Under the Affordable Care Act With Insurance Status, Cancer Stage, and Timely Treatment Among Patients With Breast, Colon, and Lung Cancer.32333293Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KABreast cancer research and treatmentRecommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.Breast Cancer Res Treat2020-04-24T00:00:002020Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium.32294617Cinar P, Kubal T, Freifeld A, Mishra A, Shulman L, Bachman J, Fonseca R, Uronis H, Klemanski D, Slusser K, Lunning M, Liu CJournal of the National Comprehensive Cancer Network : JNCCNSafety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe. J Natl Compr Canc Netw. 2020 04 15; 1-6.J Natl Compr Canc Netw2020-04-15T00:00:002020Safety at the Time of the COVID-19 Pandemic: How to Keep our Oncology Patients and Healthcare Workers Safe.Authorship 12410425Authorship 124176314Authorship 12435498Authorship 124418012Authorship 1243228632335989Schleimer LE, Desameau PG, Damuse R, Olsen M, Manzo V, Cardenas C, Mehrtash H, Krakauer EL, Masamba L, Wang C, Bhatt AS, Shulman LN, Huang FWThe oncologistAssessing and Addressing the Need for Cancer Patient Education in a Resource-Limited Setting in Haiti. Oncologist. 2020 12; 25(12):1039-1046.Oncologist2020-06-08T00:00:002020Assessing and Addressing the Need for Cancer Patient Education in a Resource-Limited Setting in Haiti.32352478Takvorian SU, Ladage VP, Wileyto EP, Mace DS, Beidas RS, Shulman LN, Bekelman JEJAMA oncologyAssociation of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology. JAMA Oncol. 2020 07 01; 6(7):1104-1106.JAMA Oncol2020-07-01T00:00:002020Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology.32333765Leach CR, Alfano CM, Potts J, Gallicchio L, Yabroff KR, Oeffinger KC, Hahn EE, Shulman LN, Hudson SVJournal of the National Cancer InstitutePersonalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities. J Natl Cancer Inst. 2020 12 14; 112(12):1183-1189.J Natl Cancer Inst2020-12-14T00:00:002020Personalized Cancer Follow-Up Care Pathways: A Delphi Consensus of Research Priorities.Authorship 1341965Authorship 1249379132437527Shulman LN, Sheldon LK, Benz EJJAMA oncologyValue of Oncology Pharmacists in the Oncology Health Care Workforce-Reply. JAMA Oncol. 2020 07 01; 6(7):1121.JAMA Oncol2020-07-01T00:00:002020Value of Oncology Pharmacists in the Oncology Health Care Workforce-Reply.Authorship 125111211Authorship 12513151032453656Singh AP, Berman AT, Marmarelis ME, Haas AR, Feigenberg SJ, Braun J, Ciunci CA, Bauml JM, Cohen RB, Kucharczuk JC, Shulman LN, Langer CJ, Aggarwal CJCO oncology practiceManagement of Lung Cancer During the COVID-19 Pandemic. JCO Oncol Pract. 2020 Sep; 16(9):579-586.JCO Oncol Pract2020-05-26T00:00:002020Management of Lung Cancer During the COVID-19 Pandemic.32453382Boffa DJ, Mallin K, Herrin J, Resio B, Salazar MC, Palis B, Facktor M, McCabe R, Nelson H, Shulman LNJAMA network openSurvival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals. JAMA Netw Open. 2020 05 01; 3(5):e203942.JAMA Netw Open2020-05-01T00:00:002020Survival After Cancer Treatment at Top-Ranked US Cancer Hospitals vs Affiliates of Top-Ranked Cancer Hospitals.Authorship 125834015Authorship 125819410Authorship 1259614832574133Kaufmann TL, Rendle KA, Aakhus E, Nimgaonkar V, Shah A, Bilger A, Gabriel PE, Trotta R, Braun J, Shulman LN, Bekelman JE, Barg FKJCO oncology practiceViews From Patients With Cancer in the Setting of Unplanned Acute Care: Informing Approaches to Reduce Health Care Utilization. JCO Oncol Pract. 2020 11; 16(11):e1291-e1303.JCO Oncol Pract2020-06-23T00:00:002020Views From Patients With Cancer in the Setting of Unplanned Acute Care: Informing Approaches to Reduce Health Care Utilization.32584461Fadelu T, Damuse R, Lormil J, Pecan E, Dubuisson C, Pierre V, Rebbeck T, Shulman LNThe oncologistPatient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort. Oncologist. 2020 09; 25(9):e1372-e1381.Oncologist2020-07-13T00:00:002020Patient Characteristics and Outcomes of Nonmetastatic Breast Cancer in Haiti: Results from a Retrospective Cohort.32562552Chua KC, Xiong C, Ho C, Mushiroda T, Jiang C, Mulkey F, Lai D, Schneider BP, Rashkin SR, Witte JS, Friedman PN, Ratain MJ, McLeod HL, Rugo HS, Shulman LN, Kubo M, Owzar K, Kroetz DLClinical pharmacology and therapeuticsGenomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy. Clin Pharmacol Ther. 2020 09; 108(3):625-634.Clin Pharmacol Ther2020-08-02T00:00:002020Genomewide Meta-Analysis Validates a Role for S1PR1 in Microtubule Targeting Agent-Induced Sensory Peripheral Neuropathy.Authorship 1438799Authorship 127044315Authorship 126825930Authorship 12697151832701365Rubagumya F, Costas-Chavarri A, Manirakiza A, Murenzi G, Uwinkindi F, Ntizimira C, Rukundo I, Mugenzi P, Rugwizangoga B, Shyirambere C, Urusaro S, Pace L, Buswell L, Ntirenganya F, Rudakemwa E, Fadelu T, Mpunga T, Shulman LN, Booth CMJCO global oncologyState of Cancer Control in Rwanda: Past, Present, and Future Opportunities. JCO Glob Oncol. 2020 07; 6:1171-1177.JCO Glob Oncol2020-07-01T00:00:002020State of Cancer Control in Rwanda: Past, Present, and Future Opportunities.32689703Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, Clark JM, Cooke D, David E, Facktor M, Farjah F, Grogan E, Isbell J, Jones DR, Kidane B, Kim AW, Keshavjee S, Krantz S, Lui N, Martin L, Meguid RA, Meyerson SL, Mullett T, Nelson H, Odell DD, Phillips JD, Puri V, Rusch V, Shulman L, Varghese TK, Wakeam E, Wood DEThe Journal of thoracic and cardiovascular surgeryCOVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network. J Thorac Cardiovasc Surg. 2020 Aug; 160(2):601-605.J Thorac Cardiovasc Surg2020-04-09T00:00:002020COVID-19 guidance for triage of operations for thoracic malignancies: A consensus statement from Thoracic Surgery Outcomes Research Network.32678711DeBoer RJ, Shyirambere C, Driscoll CD, Butera Y, Paciorek A, Ruhangaza D, Fadelu TA, Umwizerwa A, Bigirimana JB, Muhayimana C, Nguyen C, Park PH, Mpunga T, Lehmann L, Shulman LNJCO global oncologyTreatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation. JCO Glob Oncol. 2020 07; 6:1093-1102.JCO Glob Oncol2020-07-01T00:00:002020Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation.Authorship 15564925Authorship 12715133032278755Antonoff M, Backhus L, Boffa DJ, Broderick SR, Brown LM, Carrott P, Clark JM, Cooke D, David E, Facktor M, Farjah F, Grogan E, Isbell J, Jones DR, Kidane B, Kim AW, Keshavjee S, Krantz S, Lui N, Martin L, Meguid RA, Meyerson SL, Mullett T, Nelson H, Odell DD, Phillips JD, Puri V, Rusch V, Shulman L, Varghese TK, Wakeam E, Wood DEThe Annals of thoracic surgeryCOVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network. Ann Thorac Surg. 2020 08; 110(2):692-696.Ann Thorac Surg2020-04-09T00:00:002020COVID-19 Guidance for Triage of Operations for Thoracic Malignancies: A Consensus Statement From Thoracic Surgery Outcomes Research Network.Authorship 1273797332761149DeBoer RJ, Fadelu TA, Shulman LN, Van Loon KJAMA oncologyApplying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic. JAMA Oncol. 2020 09 01; 6(9):1429-1433.JAMA Oncol2020-09-01T00:00:002020Applying Lessons Learned From Low-Resource Settings to Prioritize Cancer Care in a Pandemic.Authorship 1282537932886559LeJeune A, Brock JE, Morgan EA, Kasten JL, Martei YM, Fadelu T, Rinder HM, Goulart R, Shulman LN, Milner DAJCO global oncologyHarmonization of the Essentials: Matching Diagnostics to Treatments for Global Oncology. JCO Glob Oncol. 2020 08; 6:1352-1356.JCO Glob Oncol2020-08-01T00:00:002020Harmonization of the Essentials: Matching Diagnostics to Treatments for Global Oncology.Authorship 1287464932916158Raza S, Frost E, Kwait D, Bowerson M, Rugema V, Hategekimana V, Umwizerwa A, Shabani K, Shulman L, Lee YS, Huang CC, Mpunga T, Shyirambere C, Dusengimana JV, Pace LEJournal of the American College of Radiology : JACRTraining Nonradiologist Clinicians in Diagnostic Breast Ultrasound in Rural Rwanda: Impact on Knowledge and Skills. J Am Coll Radiol. 2021 Jan; 18(1 Pt A):121-127.J Am Coll Radiol2020-09-08T00:00:002020Training Nonradiologist Clinicians in Diagnostic Breast Ultrasound in Rural Rwanda: Impact on Knowledge and Skills.Authorship 1289647932970131Manz CR, Chen J, Liu M, Chivers C, Regli SH, Braun J, Draugelis M, Hanson CW, Shulman LN, Schuchter LM, O'Connor N, Bekelman JE, Patel MS, Parikh RBJAMA oncologyValidation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer. JAMA Oncol. 2020 Nov 01; 6(11):1723-1730.JAMA Oncol2020-11-01T00:00:002020Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer.Authorship 1880746Authorship 129222710Authorship 1292526632997538Pace LE, Schleimer LE, Shyirambere C, Ilbawi A, Dusengimana JMV, Bigirimana JB, Uwizeye FR, Chamberlin M, Lee YS, Shulman LN, Troyan S, Anderson BO, Duggan C, O'Neil DS, Dvaladze A, Brock J, Nguyen C, Ruhangaza D, Habimana O, Nsabimana N, Butonzi J, Nkusi E, Mpunga T, Keating NLJCO global oncologyIdentifying Breast Cancer Care Quality Measures for a Cancer Facility in Rural Sub-Saharan Africa: Results of a Systematic Literature Review and Modified Delphi Process. JCO Glob Oncol. 2020 09; 6:1446-1454.JCO Glob Oncol2020-09-01T00:00:002020Identifying Breast Cancer Care Quality Measures for a Cancer Facility in Rural Sub-Saharan Africa: Results of a Systematic Literature Review and Modified Delphi Process.32983913Habinshuti P, Hagenimana M, Nguyen C, Park PH, Mpunga T, Shulman LN, Fehr A, Rukundo G, Bigirimana JB, Teeple S, Kigonya C, Ndayisaba GF, Uwinkindi F, Randall T, Miller ACAnnals of global healthFactors Associated with Loss to Follow-up among Cervical Cancer Patients in Rwanda. Ann Glob Health. 2020 09 14; 86(1):117.Ann Glob Health2020-09-14T00:00:002020Factors Associated with Loss to Follow-up among Cervical Cancer Patients in Rwanda.Authorship 129751012Authorship 1296989233057696Manz CR, Parikh RB, Small DS, Evans CN, Chivers C, Regli SH, Hanson CW, Bekelman JE, Rareshide CAL, O'Connor N, Schuchter LM, Shulman LN, Patel MSJAMA oncologyEffect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Oncol. 2020 Dec 01; 6(12):e204759.JAMA Oncol2020-12-01T00:00:002020Effect of Integrating Machine Learning Mortality Estimates With Behavioral Nudges to Clinicians on Serious Illness Conversations Among Patients With Cancer: A Stepped-Wedge Cluster Randomized Clinical Trial.33090180Frosch ZAK, Shulman LN, Bekelman JEJAMA oncologyIndependent Oncology Practices in the COVID-19 Era-Does US Cancer Care Need a Bailout? JAMA Oncol. 2021 03 01; 7(3):347-348.JAMA Oncol2021-03-01T00:00:002021Independent Oncology Practices in the COVID-19 Era-Does US Cancer Care Need a Bailout?Authorship 129899415Authorship 1299662333126204Sugalski J, Franco T, Shulman LN, Cinar P, Bachman J, Crews JR, Olsen M, Schatz A, Kubal TJournal of the National Comprehensive Cancer Network : JNCCNCreative Strategies Implemented During the Coronavirus Pandemic That Will Impact the Future of Cancer Care. J Natl Compr Canc Netw. 2020 Oct 30; 1-5.J Natl Compr Canc Netw2020-10-30T00:00:002020Creative Strategies Implemented During the Coronavirus Pandemic That Will Impact the Future of Cancer Care.27334457Yaari R, Kaliner E, Grotto I, Katriel G, Moran-Gilad J, Sofer D, Mendelson E, Miller E, Huppert A, Anis E, Kopel E, Manor Y, Mor O, Shulman L, Singer R, Weil MBMC medicineModeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel. BMC Med. 2016 06 23; 14(1):95.BMC Med2016-06-23T00:00:002016Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.Authorship 13052179Authorship 1305165933151772Gralow JR, Asirwa FC, Bhatt AS, Bourlon MT, Chu Q, Eniu AE, Loehrer PJ, Lopes G, Shulman LN, Close J, Von Roenn J, Tibbits M, Pyle DJCO global oncologyRecommendations from the ASCO Academic Global Oncology Task Force. JCO Glob Oncol. 2020 10; 6:1666-1673.JCO Glob Oncol2020-10-01T00:00:002020Recommendations from the ASCO Academic Global Oncology Task Force.33151773Fadelu T, Damuse R, Lormil J, Pecan E, Greenberg L, Dubuisson C, Pierre V, Triedman SA, Shulman LN, Rebbeck TRJCO global oncologyBody Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast Cancer. JCO Glob Oncol. 2020 10; 6:1656-1665.JCO Glob Oncol2020-10-01T00:00:002020Body Mass Index, Chemotherapy-Related Weight Changes, and Disease-Free Survival in Haitian Women With Nonmetastatic Breast Cancer.Authorship 13235101533493021Blanchard C, Lubuzo B, Asirwa FC, Dlamini X, Msadabwe-Chikuni SC, Mwachiro M, Shyirambere C, Ruhangaza D, Milner DA, Van Loon K, DeBoer R, Mtshali P, Dugan U, Baker E, Shulman LNJCO global oncologyMultisector Collaborations and Global Oncology: The Only Way Forward. JCO Glob Oncol. 2021 01; 7:153-161.JCO Glob Oncol2021-01-01T00:00:002021Multisector Collaborations and Global Oncology: The Only Way Forward.Authorship 1328956533577718Williams AD, Sun T, Kakade S, Wong SL, Shulman LN, Carp NZJournal of surgical oncologyComparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure. J Surg Oncol. 2021 Mar; 123(4):986-996.J Surg Oncol2021-02-12T00:00:002021Comparison of open and minimally invasive approaches to colon cancer resection in compliance with 12 regional lymph node harvest quality measure.Authorship 13374332Authorship 13370001533710914Hawrot K, Shulman LN, Bleiweiss IJ, Wilkie EJ, Frosch ZAK, Jankowitz RC, Laughlin AIJCO oncology practiceTime to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic. JCO Oncol Pract. 2021 09; 17(9):534-540.JCO Oncol Pract2021-03-12T00:00:002021Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic.33676609Hricak H, Abdel-Wahab M, Atun R, Lette MM, Paez D, Brink JA, Donoso-Bach L, Frija G, Hierath M, Holmberg O, Khong PL, Lewis JS, McGinty G, Oyen WJG, Shulman LN, Ward ZJ, Scott AMThe Lancet. OncologyMedical imaging and nuclear medicine: a Lancet Oncology Commission. Lancet Oncol. 2021 04; 22(4):e136-e172.Lancet Oncol2021-03-04T00:00:002021Medical imaging and nuclear medicine: a Lancet Oncology Commission.Authorship 1354724933969927DeBoer RJ, Mutoniwase E, Nguyen C, Ho A, Umutesi G, Nkusi E, Sebahungu F, Van Loon K, Shulman LN, Shyirambere CThe oncologistMoral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited Context. Oncologist. 2021 07; 26(7):e1189-e1196.Oncologist2021-05-28T00:00:002021Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited Context.Authorship 1360678534077835DeStefano LM, Coffua L, Wilson E, Tchou J, Shulman LN, Feldman M, Brooks A, Sataloff D, Fisher CSSurgical oncologyRisk factors for the presence of residual disease in women after partial mastectomy for invasive breast cancer: A single institution experience. Surg Oncol. 2021 Jun; 37:101608.Surg Oncol2021-05-25T00:00:002021Risk factors for the presence of residual disease in women after partial mastectomy for invasive breast cancer: A single institution experience.Authorship 13627571734115135Rivara FP, Bradley SM, Catenacci DV, Desai AN, Ganguli I, Haneuse SJPA, Inouye SK, Jacobs EA, Kan K, Kim HS, Morris AM, Ogedegbe O, Perencevich EN, Perlis RH, Powell E, Rubenfeld GD, Shulman LN, Trueger NS, Fihn SDJAMA network openStructural Racism and JAMA Network Open. JAMA Netw Open. 2021 06 01; 4(6):e2120269.JAMA Netw Open2021-06-01T00:00:002021Structural Racism and JAMA Network Open.Authorship 13647151034137216Perkons NR, Kim C, Boedec C, Keele LJ, Schneider C, Teitelbaum UR, Ben-Josef E, Gabriel PE, Plastaras JP, Shulman LN, Wojcieszynski APCancer reports (Hoboken, N.J.)Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery. Cancer Rep (Hoboken). 2022 01; 5(1):e1427.Cancer Rep (Hoboken)2021-06-17T00:00:002021Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.Authorship 172207Authorship 1372978934241630Frosch ZAK, Illenberger N, Mitra N, Boffa DJ, Facktor MA, Nelson H, Palis BE, Bekelman JE, Shulman LN, Takvorian SUJAMA network openTrends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation. JAMA Netw Open. 2021 07 01; 4(7):e2115675.JAMA Netw Open2021-07-01T00:00:002021Trends in Patient Volume by Hospital Type and the Association of These Trends With Time to Cancer Treatment Initiation.Authorship 13748429Authorship 13759261434253674Davey S, Grover S, Bilker WB, Setlhako DI, Ralefala TB, Manshimba P, Gross R, DeMichele A, Shulman LN, Martei YMBMJ openRetrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana. BMJ Open. 2021 07 12; 11(7):e049574.BMJ Open2021-07-12T00:00:002021Retrospective cohort analysis of prescription patterns of cancer medications during periods of drug stockouts in Botswana.34266468Jenssen BP, Schnoll R, Beidas R, Bekelman J, Bauer AM, Scott C, Evers-Casey S, Nicoloso J, Gabriel P, Asch DA, Buttenheim A, Chen J, Melo J, Shulman LN, Clifton ABW, Lieberman A, Salam T, Zentgraf K, Rendle KA, Chaiyachati K, Shelton R, Wileyto EP, Ware S, Leone FImplementation science : ISRationale and protocol for a cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment rates for cancer patients who smoke. Implement Sci. 2021 07 15; 16(1):72.Implement Sci2021-07-15T00:00:002021Rationale and protocol for a cluster randomized pragmatic clinical trial testing behavioral economic implementation strategies to improve tobacco treatment rates for cancer patients who smoke.Authorship 1546262Authorship 1383722934390287Ralefala T, Mokokwe L, Jammalamadugu S, Legobere D, Motlhwa WS, Oyekunle AA, Grover S, Barg FK, Shulman LN, Martei YMThe oncologistProvider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis. Oncologist. 2021 12; 26(12):e2200-e2208.Oncologist2021-09-02T00:00:002021Provider Barriers and Facilitators of Breast Cancer Guideline-Concordant Therapy Delivery in Botswana: A Consolidated Framework for Implementation Research Analysis.Authorship 13859399Authorship 13867551311797770Bin H, Grossman Z, Pokamunski S, Malkinson M, Weiss L, Duvdevani P, Banet C, Weisman Y, Annis E, Gandaku D, Yahalom V, Hindyieh M, Shulman L, Mendelson EAnnals of the New York Academy of SciencesWest Nile fever in Israel 1999-2000: from geese to humans. Ann N Y Acad Sci. 2001 Dec; 951:127-42.Ann N Y Acad Sci2001-12-01T00:00:002001West Nile fever in Israel 1999-2000: from geese to humans.34416159Ward ZJ, Atun R, Hricak H, Asante K, McGinty G, Sutton EJ, Norton L, Scott AM, Shulman LNThe Lancet. OncologyThe impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis. Lancet Oncol. 2021 09; 22(9):1301-1311.Lancet Oncol2021-08-17T00:00:002021The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.Authorship 13950071134523005Soegaard Ballester JM, Goodsell KE, Ermer JP, Karakousis GC, Miura JT, Saur NM, Mahmoud NN, Brooks A, Tchou JC, Gabriel PE, Shulman LN, Wachtel HAnnals of surgical oncologyNew Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation. Ann Surg Oncol. 2022 Mar; 29(3):1797-1804.Ann Surg Oncol2021-09-14T00:00:002021New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation.Authorship 139907221Authorship 140036511Authorship 14010601934606296Hwang S, Bozkurt B, Huson T, Asad S, Richardson L, Ogbansiegbe JA, Viera L, Buse C, James TA, Mayer DK, Shulman LN, Birken SAJCO oncology practiceIdentifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer Programs. JCO Oncol Pract. 2022 03; 18(3):e304-e312.JCO Oncol Pract2021-10-04T00:00:002021Identifying Strategies for Robust Survivorship Program Implementation: A Qualitative Analysis of Cancer Programs.34611665Parikh RB, Takvorian SU, Vader D, Wileyto EP, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RAmedRxiv : the preprint server for health sciencesImpact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer. medRxiv. 2021 Sep 23.medRxiv2021-09-23T00:00:002021Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer.34563227Takvorian SU, Bekelman J, Beidas RS, Schnoll R, Clifton ABW, Salam T, Gabriel P, Wileyto EP, Scott CA, Asch DA, Buttenheim AM, Rendle KA, Chaiyachati K, Shelton RC, Ware S, Chivers C, Schuchter LM, Kumar P, Shulman LN, O'Connor N, Lieberman A, Zentgraf K, Parikh RBImplementation science : ISBehavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial. Implement Sci. 2021 09 25; 16(1):90.Implement Sci2021-09-25T00:00:002021Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial.Authorship 140255611Authorship 1403159534635061Nimgaonkar V, Aggarwal C, Berman AT, Gabriel P, Shulman LN, Kucharczuk J, Roy M, Bauml JM, Singh AP, Cohen RB, Langer CJ, Marmarelis MEBMC cancerImpact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic. BMC Cancer. 2021 Oct 11; 21(1):1094.BMC Cancer2021-10-11T00:00:002021Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic.34642847Soegaard Ballester JM, Goodsell KE, Ermer JP, Karakousis GC, Miura JT, Saur NM, Mahmoud NN, Brooks A, Tchou JC, Gabriel PE, Shulman LN, Wachtel HAnnals of surgical oncologyASO Visual Abstract: New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation. Ann Surg Oncol. 2021 Dec; 28(Suppl 3):766-767.Ann Surg Oncol2021-12-01T00:00:002021ASO Visual Abstract: New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation.Authorship 14099681134767436Cotner CE, Balachandran M, Do D, Ferrell W, Khan N, Kopinsky M, McGettigan S, Morgan AU, Zinck L, Schuchter LM, Shulman LN, Asch DA, Manz CR, Parikh RBJCO clinical cancer informaticsAutomated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19. JCO Clin Cancer Inform. 2021 10; 5:1134-1140.JCO Clin Cancer Inform2021-10-01T00:00:002021Automated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19.Authorship 14178903Authorship 14182022134893865Parikh RB, Takvorian SU, Vader D, Paul Wileyto E, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RAJournal of the National Cancer InstituteImpact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States. J Natl Cancer Inst. 2022 04 11; 114(4):571-578.J Natl Cancer Inst2022-04-11T00:00:002022Impact of the COVID-19 Pandemic on Treatment Patterns for Patients With Metastatic Solid Cancer in the United States.34882172DeBoer RJ, Rugo HS, Shulman LNJAMA oncologyReconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality. JAMA Oncol. 2022 02 01; 8(2):203-204.JAMA Oncol2022-02-01T00:00:002022Reconceptualizing Risk-Benefit Assessment of Novel Cancer Therapies to Expand Global Access and Reduce Worldwide Mortality.Authorship 14191791234916066DeBoer RJ, Umutoni V, Bazzett-Matabele L, Katznelson E, Nguyen C, Umwizerwa A, Bigirimana JB, Paciorek A, Nsabimana N, Ruhangaza D, Ntasumbumuyange D, Shulman LN, Triedman SA, Shyirambere CGynecologic oncologyCervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes. Gynecol Oncol. 2022 02; 164(2):370-378.Gynecol Oncol2021-12-14T00:00:002021Cervical cancer treatment in Rwanda: Resource-driven adaptations, quality indicators, and patient outcomes.Authorship 1421978334991065Sugalski JM, Franco T, Shulman LN, Souza E, Hochberg E, Chiang A, Lawrence S, Krause D, Kubal TJournal of the National Comprehensive Cancer Network : JNCCNCOVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee. J Natl Compr Canc Netw. 2022 01 06; 20(13).J Natl Compr Canc Netw2022-01-06T00:00:002022COVID-19 and Cancer Center Operations: Lessons Learned From the NCCN Best Practices Committee.Authorship 1970367TF60TemidayoFadeluTemidayo Fadelu, M.D.119079Fadelu, TemidayoAssistant Professor of MedicineAuthorship 1430323835094138Parikh RB, Manz CR, Nelson MN, Evans CN, Regli SH, O'Connor N, Schuchter LM, Shulman LN, Patel MS, Paladino J, Shea JASupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerClinician perspectives on machine learning prognostic algorithms in the routine care of patients with cancer: a qualitative study. Support Care Cancer. 2022 May; 30(5):4363-4372.Support Care Cancer2022-01-30T00:00:002022Clinician perspectives on machine learning prognostic algorithms in the routine care of patients with cancer: a qualitative study.Authorship 14417576Authorship 1437520735358453Sullivan R, Lewison G, Torode J, Kingham PT, Brennan M, Shulman LN, Lawler M, Aggarwal A, Gralow JThe Lancet. OncologyCancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement. Lancet Oncol. 2022 04; 23(4):460-462.Lancet Oncol2022-04-01T00:00:002022Cancer research collaboration between the UK and the USA: reflections on the 2021 G20 Summit announcement.35333494Davidson NE, Knudsen KE, Nasso SF, Oyer R, Pergam S, Strawbridge L, Shulman LCancer journal (Sudbury, Mass.)Cancer Care at the Beginning of the COVID-19 Pandemic: Effects on Patients and Early Interventions to Mitigate Stresses on Care. Cancer J. 2022 Mar-Apr 01; 28(2):107-110.Cancer J2022-03-01T00:00:002022Cancer Care at the Beginning of the COVID-19 Pandemic: Effects on Patients and Early Interventions to Mitigate Stresses on Care.Authorship 14443145Authorship 14471928Authorship 1448351835377734Sedhom R, Blackford AL, Gupta A, Smith TJ, Shulman LN, Carducci MAJCO oncology practiceOncologist Peer Comparisons as a Behavioral Science Strategy to Improve Hospice Utilization. JCO Oncol Pract. 2022 07; 18(7):e1122-e1131.JCO Oncol Pract2022-04-04T00:00:002022Oncologist Peer Comparisons as a Behavioral Science Strategy to Improve Hospice Utilization.35420316Fadelu TA, Erfani P, Lormil J, Damuse R, Pierre V, Slater S, Triedman SA, Shulman LN, Rebbeck TRBreast cancer research and treatmentGaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):625-635.Breast Cancer Res Treat2022-04-14T00:00:002022Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer.35438165Bradley CJ, Kitchen S, Bhatia S, Bynum J, Darien G, Lichtenfeld JL, Oyer R, Shulman LN, Sheldon LKJournal of the National Cancer InstitutePolicies and Practices to Address Cancer's Long-Term Adverse Consequences. J Natl Cancer Inst. 2022 08 08; 114(8):1065-1071.J Natl Cancer Inst2022-08-08T00:00:002022Policies and Practices to Address Cancer's Long-Term Adverse Consequences.Authorship 145091611Authorship 1452405835584347Martei YM, Narasimhamurthy M, Setlhako DI, Ayane G, Ralefala T, Chiyapo S, Gross R, Shulman LN, Grover S, DeMichele AJCO global oncologyRelative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy. JCO Glob Oncol. 2022 05; 8:e2200016.JCO Glob Oncol2022-05-01T00:00:002022Relative Dose Intensity and Pathologic Response Rates in Patients With Breast Cancer and With and Without HIV Who Received Neoadjuvant Chemotherapy.35551088Parikh RB, Ferrell W, Wakim J, Williamson J, Khan N, Kopinsky M, Balachandran M, Gabriel PE, Zhang Y, Schuchter LM, Shulman LN, Chen J, Patel MS, Manz CRBMJ openPatient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial. BMJ Open. 2022 05 12; 12(5):e054675.BMJ Open2022-05-12T00:00:002022Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.Authorship 1538637Authorship 14610658Authorship 14582443Authorship 146663112Authorship 146047410Authorship 14578868Authorship 146104513Authorship 146026911Authorship 14604839Authorship 146279212Authorship 14637174Authorship 14654744Authorship 14686889Authorship 1462678135675586Takvorian SU, Anderson RT, Gabriel PE, Poznyak D, Lee S, Simon S, Barrett K, Shulman LNJCO oncology practiceReal-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric. JCO Oncol Pract. 2022 09; 18(9):e1454-e1465.JCO Oncol Pract2022-06-08T00:00:002022Real-World Adherence to Patient-Reported Outcome Monitoring as a Cancer Care Quality Metric.35659482Lin JK, Jacobs LA, Blauch A, Shulman LN, Vaughn DJUrologic oncologyGuideline discordant care in patients with metastatic germ cell tumors. Urol Oncol. 2022 08; 40(8):385.e9-385.e17.Urol Oncol2022-06-01T00:00:002022Guideline discordant care in patients with metastatic germ cell tumors.35640129Shulman LNJournal of the National Cancer InstituteThe National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward. J Natl Cancer Inst. 2022 09 09; 114(9):1212-1213.J Natl Cancer Inst2022-09-09T00:00:002022The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward.35839427Morgan J, DeBoer RJ, Bigirimana JB, Nguyen C, Ruhangaza D, Paciorek A, Mugabo F, Villaverde C, Nsabimana N, Bihizimana P, Umwizerwa A, Lehmann LE, Shulman LN, Shyirambere CJCO global oncologyA Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape. JCO Glob Oncol. 2022 07; 8:e2200131.JCO Glob Oncol2022-07-01T00:00:002022A Ten-Year Experience of Treating Chronic Myeloid Leukemia in Rural Rwanda: Outcomes and Insights for a Changing Landscape.35772820Nambaziira R, Niteka LC, Dusengimana JMV, Ruhumuriza J, Bhangdia KP, Mugunga JC, Uwineza ML, Rugema V, Erfani P, Shyirambere C, Shulman LN, Rabideau M, Pace LEBMJ openHealth system costs of a breast cancer early diagnosis programme in a rural district of Rwanda: a retrospective, cross-sectional economic analysis. BMJ Open. 2022 06 30; 12(6):e062357.BMJ Open2022-06-30T00:00:002022Health system costs of a breast cancer early diagnosis programme in a rural district of Rwanda: a retrospective, cross-sectional economic analysis.35738413Pace LE, Dusengimana JV, Hategekimana V, Rugema V, Umwizerwa A, Frost E, Kwait D, Schleimer LE, Huang C, Shyirambere C, Bigirimana JB, Shulman LN, Mpunga T, Raza SJournal of the American College of Radiology : JACRClinical Diagnoses and Outcomes After Diagnostic Breast Ultrasound by Nurses and General Practitioner Physicians in Rural Rwanda. J Am Coll Radiol. 2022 08; 19(8):983-989.J Am Coll Radiol2022-06-20T00:00:002022Clinical Diagnoses and Outcomes After Diagnostic Breast Ultrasound by Nurses and General Practitioner Physicians in Rural Rwanda.35623016Fadelu T, Nadella P, Iyer HS, Uwikindi F, Shyirambere C, Manirakiza A, Triedman SA, Rebbeck TR, Shulman LNJCO global oncologyToward Equitable Access to Tertiary Cancer Care in Rwanda: A Geospatial Analysis. JCO Glob Oncol. 2022 05; 8:e2100395.JCO Glob Oncol2022-05-01T00:00:002022Toward Equitable Access to Tertiary Cancer Care in Rwanda: A Geospatial Analysis.10325305Manor Y, Handsher R, Halmut T, Neuman M, Bobrov A, Rudich H, Vonsover A, Shulman L, Kew O, Mendelson EJournal of clinical microbiologyDetection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority. J Clin Microbiol. 1999 Jun; 37(6):1670-5.J Clin Microbiol1999-06-01T00:00:001999Detection of poliovirus circulation by environmental surveillance in the absence of clinical cases in Israel and the Palestinian authority.35649215Mikhail Lette MN, Paez D, Shulman LN, Guckenberger M, Douillard JY, Oyen WJG, Giammarile F, Rangarajan V, Ginsberg M, Pellet O, Liao Z, Abdel Wahab MJCO global oncologyToward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine. JCO Glob Oncol. 2022 05; 8:e2100100.JCO Glob Oncol2022-05-01T00:00:002022Toward Improved Outcomes for Patients With Lung Cancer Globally: The Essential Role of Radiology and Nuclear Medicine.35622812Li E, Manz C, Liu M, Chen J, Chivers C, Braun J, Schuchter LM, Kumar P, Patel MS, Shulman LN, Parikh RBPloS oneOncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial. PLoS One. 2022; 17(5):e0267012.PLoS One2022-05-27T00:00:002022Oncologist phenotypes and associations with response to a machine learning-based intervention to increase advance care planning: Secondary analysis of a randomized clinical trial.35640986Parikh RB, Basen-Enquist KM, Bradley C, Estrin D, Levy M, Lichtenfeld JL, Malin B, McGraw D, Meropol NJ, Oyer RA, Sheldon LK, Shulman LNJournal of the National Cancer InstituteDigital Health Applications in Oncology: An Opportunity to Seize. J Natl Cancer Inst. 2022 10 06; 114(10):1338-1339.J Natl Cancer Inst2022-10-06T00:00:002022Digital Health Applications in Oncology: An Opportunity to Seize.35820081Shyirambere C, Villaverde C, Nguyen C, Ruhangaza D, Umwizerwa A, Nsanzimana O, Mujyuwisha L, Iradukunda E, Shulman LN, Lehmann LJCO global oncologyNephroblastoma Treatment and Outcomes in a Low-Income Setting. JCO Glob Oncol. 2022 07; 8:e2200036.JCO Glob Oncol2022-07-01T00:00:002022Nephroblastoma Treatment and Outcomes in a Low-Income Setting.35603309Dos-Santos-Silva I, Gupta S, Orem J, Shulman LNCommunications medicineGlobal disparities in access to cancer care. Commun Med (Lond). 2022; 2:31.Commun Med (Lond)2022-04-07T00:00:002022Global disparities in access to cancer care.Authorship 14915838Authorship 14999216Authorship 15000527Authorship 1497923636036938Bange EM, Coughlin K, Li W, Moriarty E, Brown TJ, Shulman LN, Mamtani RJAMA network openAccuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors. JAMA Netw Open. 2022 08 01; 5(8):e2228452.JAMA Netw Open2022-08-01T00:00:002022Accuracy of a Text Intervention to Minimize the Burden of Cancer Care Among Patients Treated With Immune Checkpoint Inhibitors.36094141Kizub DA, Naik S, Abogan AA, Pain D, Sammut S, Shulman LN, Martei YMThe oncologistAccess to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda. Oncologist. 2022 Nov 03; 27(11):958-970.Oncologist2022-11-03T00:00:002022Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.36130286Graboyes EM, Chaiyachati KH, Sisto Gall J, Johnson W, Krishnan JA, McManus SS, Thompson L, Shulman LN, Yabroff KRJournal of the National Cancer InstituteAddressing Transportation Insecurity Among Patients With Cancer. J Natl Cancer Inst. 2022 12 08; 114(12):1593-1600.J Natl Cancer Inst2022-12-08T00:00:002022Addressing Transportation Insecurity Among Patients With Cancer.36252158Erfani P, Bates M, Garcia-Gonzalez P, Milner DA, Rebbeck TR, Ruhangaza D, Shulman LN, Fadelu TJCO global oncologyLeveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap. JCO Glob Oncol. 2022 Oct; 8:e2200182.JCO Glob Oncol2022-10-01T00:00:002022Leveraging Molecular Diagnostic Technologies to Close the Global Cancer Pathology Gap.Authorship 447058true1Associate Professor of MedicineAssociate Professor of MedicineAuthorship 1683972Authorship 15110799Authorship 1511903836508703Uwimana A, Dessalegn S, Vianney Dusengimana JM, Stauber C, Fata A, Hagenimana M, Uwinkindi F, Balinda JP, Shulman LN, Revette A, Rwamuza E, Pace LEJCO global oncologyIntegrating Breast Cancer Early Detection Into a Resource-Constrained Primary Health Care System: Health Care Workers' Experiences in Rwanda. JCO Glob Oncol. 2022 12; 8:e2200181.JCO Glob Oncol2022-12-01T00:00:002022Integrating Breast Cancer Early Detection Into a Resource-Constrained Primary Health Care System: Health Care Workers' Experiences in Rwanda.36593782Erfani P, Gaga E, Hakizimana E, Kayitare E, Mugunga JC, Shyirambere C, Milner DA, Shulman LN, Ruhangaza D, Fadelu TBulletin of the World Health OrganizationBreast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay. Bull World Health Organ. 2023 Jan 01; 101(1):10-19.Bull World Health Organ2022-11-02T00:00:002022Breast cancer molecular diagnostics in Rwanda: a cost-minimization study of immunohistochemistry versus a novel GeneXpert® mRNA expression assay.Authorship 21510813Authorship 15168593Authorship 151589813Authorship 15169945Authorship 15158743Authorship 1516866162229623Tavares M, Branch LG, Shulman LJournal of dental educationDental implant patients and their satisfaction with treatment. J Dent Educ. 1990 Nov; 54(11):670-9.J Dent Educ1990-11-01T00:00:001990Dental implant patients and their satisfaction with treatment.36633843Gabriel PE, Singh AP, Shulman LNJAMA oncologyRe-envisioning the Paradigm for Oncology Electronic Health Record Documentation by Paying for What Matters for Patients, Quality, and Research. JAMA Oncol. 2023 03 01; 9(3):299-300.JAMA Oncol2023-03-01T00:00:002023Re-envisioning the Paradigm for Oncology Electronic Health Record Documentation by Paying for What Matters for Patients, Quality, and Research.24679737Moonen AJ, Wijers A, Leentjens AF, Christine CW, Factor SA, Juncos J, Lyness JM, Marsh L, Panisset M, Pfeiffer R, Rottenberg D, Serrano Ramos C, Shulman L, Singer C, Slevin J, McDonald W, Auinger P, Richard IHParkinsonism & related disordersSeverity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism Relat Disord. 2014 Jun; 20(6):644-6.Parkinsonism Relat Disord2014-03-18T00:00:002014Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.36633868Manz CR, Zhang Y, Chen K, Long Q, Small DS, Evans CN, Chivers C, Regli SH, Hanson CW, Bekelman JE, Braun J, Rareshide CAL, O'Connor N, Kumar P, Schuchter LM, Shulman LN, Patel MS, Parikh RBJAMA oncologyLong-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical Trial. JAMA Oncol. 2023 03 01; 9(3):414-418.JAMA Oncol2023-03-01T00:00:002023Long-term Effect of Machine Learning-Triggered Behavioral Nudges on Serious Illness Conversations and End-of-Life Outcomes Among Patients With Cancer: A Randomized Clinical Trial.36634609Chaiyachati KH, Krause D, Sugalski J, Graboyes EM, Shulman LNJournal of the National Comprehensive Cancer Network : JNCCNA Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients' Transportation Insecurity. J Natl Compr Canc Netw. 2023 01; 21(1):21-26.J Natl Compr Canc Netw2023-01-01T00:00:002023A Survey of the National Comprehensive Cancer Network on Approaches Toward Addressing Patients' Transportation Insecurity.Authorship 15189051336705922Perlis RH, Kendall-Taylor J, Hart K, Ganguli I, Berlin JA, Bradley SM, Haneuse S, Inouye SK, Jacobs EA, Morris A, Ogedegbe O, Perencevich E, Shulman LN, Trueger NS, Fihn SD, Rivara FP, Flanagin AJAMA network openPeer Review in a General Medical Research Journal Before and During the COVID-19 Pandemic. JAMA Netw Open. 2023 01 03; 6(1):e2253296.JAMA Netw Open2023-01-03T00:00:002023Peer Review in a General Medical Research Journal Before and During the COVID-19 Pandemic.Authorship 1521674636725167Nadella P, Iyer HS, Manirakiza A, Vanderpuye V, Triedman SA, Shulman LN, Fadelu TInternational journal of radiation oncology, biology, physicsGeographic Accessibility of Radiation Therapy Facilities in Sub-Saharan Africa. Int J Radiat Oncol Biol Phys. 2023 03 01; 115(3):557-563.Int J Radiat Oncol Biol Phys2023-03-01T00:00:002023Geographic Accessibility of Radiation Therapy Facilities in Sub-Saharan Africa.Authorship 1982017Authorship 47685712Authorship 2008147Authorship 15700593Authorship 15548593Authorship 15666532Authorship 15660573Authorship 156931918Authorship 157336110Authorship 15612131437499192Aggarwal C, Marmarelis ME, Hwang WT, Scholes DG, McWilliams TL, Singh AP, Sun L, Kosteva J, Costello MR, Cohen RB, Langer CJ, Doucette A, Gabriel PN, Shulman LN, Rendle KA, Thompson JC, Bekelman JE, Carpenter ELJCO precision oncologyAssociation Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 07; 7:e2300191.JCO Precis Oncol2023-07-01T00:00:002023Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.37397178Pace LE, Hagenimana M, Dusengimana JV, Balinda JP, Benewe O, Rugema V, de Dieu Uwihaye J, Fata A, Shyirambere C, Shulman LN, Keating NL, Uwinkindi FBulletin of the World Health OrganizationImplementation research: including breast examinations in a cervical cancer screening programme, Rwanda. Bull World Health Organ. 2023 Jul 01; 101(7):478-486.Bull World Health Organ2023-05-26T00:00:002023Implementation research: including breast examinations in a cervical cancer screening programme, Rwanda.37071103Boffa DJ, Nelson H, Shulman LNJAMAThe Growth of Medical Knowledge and Data Sharing. JAMA. 2023 04 18; 329(15):1314-1315.JAMA2023-04-18T00:00:002023The Growth of Medical Knowledge and Data Sharing.37084327Sedhom R, Shulman LN, Parikh RBJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrecision Palliative Care as a Pragmatic Solution for a Care Delivery Problem. J Clin Oncol. 2023 06 01; 41(16):2888-2892.J Clin Oncol2023-04-21T00:00:002023Precision Palliative Care as a Pragmatic Solution for a Care Delivery Problem.37467454Jenssen BP, Schnoll R, Beidas RS, Bekelman J, Bauer AM, Evers-Casey S, Fisher T, Scott C, Nicoloso J, Gabriel P, Asch DA, Buttenheim AM, Chen J, Melo J, Grant D, Horst M, Oyer R, Shulman LN, Clifton ABW, Lieberman A, Salam T, Rendle KA, Chaiyachati KH, Shelton RC, Fayanju O, Wileyto EP, Ware S, Blumenthal D, Ragusano D, Leone FTJournal of clinical oncology : official journal of the American Society of Clinical OncologyCluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke. J Clin Oncol. 2023 10 01; 41(28):4511-4521.J Clin Oncol2023-07-19T00:00:002023Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke.37289446Gabriel PE, Singh AP, Shulman LNJAMA oncologyStandardized Documentation Is Not the Solution to Reduce Physician Time in the Electronic Health Record-Reply. JAMA Oncol. 2023 08 01; 9(8):1152.JAMA Oncol2023-08-01T00:00:002023Standardized Documentation Is Not the Solution to Reduce Physician Time in the Electronic Health Record-Reply.37290022Davies L, Milner DA, Shulman LN, Kyokunda L, Bedada A, Vuylsteke P, Masalu N, Jackson P, Jennings N, Odunlami A, Mtshali P, Dugan UJCO global oncologyAnalysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities. JCO Glob Oncol. 2023 Jun; 9:e2200203.JCO Glob Oncol2023-06-01T00:00:002023Analysis of Cancer Research Projects in Sub-Saharan Africa: A Quantitative Perspective on Unmet Needs and Opportunities.Authorship 2303801Authorship 33929812Authorship 1590506937646967Pace LE, Fata AM, Cubaka VK, Nsemgiyumva T, Uwihaye JD, Stauber C, Dusengimana JV, Bhangdia K, Shulman LN, Revette A, Hagenimana M, Uwinkindi F, Rwamuza EBreast cancer research and treatmentPatients' experiences undergoing breast evaluation in Rwanda's Women's Cancer Early Detection Program. Breast Cancer Res Treat. 2023 Dec; 202(3):541-550.Breast Cancer Res Treat2023-08-30T00:00:002023Patients' experiences undergoing breast evaluation in Rwanda's Women's Cancer Early Detection Program.Authorship 15969491237816198Parikh RB, Schriver E, Ferrell WJ, Wakim J, Williamson J, Khan N, Kopinsky M, Balachandran M, Gabriel PE, Schuchter LM, Patel MS, Shulman LN, Manz CRJCO oncology practiceRemote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial. JCO Oncol Pract. 2023 Dec; 19(12):1143-1151.JCO Oncol Pract2023-10-10T00:00:002023Remote Patient-Reported Outcomes and Activity Monitoring to Improve Patient-Clinician Communication Regarding Symptoms and Functional Status: A Randomized Controlled Trial.true1Lecturer on Global Health and Social Medicine, Part-timeLecturer on Global Health and Social Medicine, Part-timetrue1Richard and Susan Smith Distinguished Professor of MedicineRichard and Susan Smith Distinguished Professor of MedicineAuthorship 1602531637878313Lipsyc-Sharf M, Ballman KV, Campbell JD, Muss HB, Perez EA, Shulman LN, Carey LA, Partridge AH, Warner ETJAMA network openAge, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival. JAMA Netw Open. 2023 10 02; 6(10):e2339584.JAMA Netw Open2023-10-02T00:00:002023Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival.true1Associate Professor of PediatricsAssociate Professor of PediatricsAuthorship 16050522537932730Symecko H, Schnoll R, Beidas RS, Bekelman JE, Blumenthal D, Bauer AM, Gabriel P, Boisseau L, Doucette A, Powers J, Cappadocia J, McKenna DB, Richardville R, Cuff L, Offer R, Clement EG, Buttenheim AM, Asch DA, Rendle KA, Shelton RC, Fayanju OM, Wileyto EP, Plag M, Ware S, Shulman LN, Nathanson KL, Domchek SMImplementation science : ISProtocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices. Implement Sci. 2023 11 06; 18(1):57.Implement Sci2023-11-06T00:00:002023Protocol to evaluate sequential electronic health record-based strategies to increase genetic testing for breast and ovarian cancer risk across diverse patient populations in gynecology practices.true1Professor of Health Care PolicyProfessor of Health Care PolicyAuthorship 16109992538001506McCarthy AM, Fernandez Perez C, Beidas RS, Bekelman JE, Blumenthal D, Mack E, Bauer AM, Ehsan S, Conant EF, Wheeler BC, Guerra CE, Nunes LW, Gabriel P, Doucette A, Wileyto EP, Buttenheim AM, Asch DA, Rendle KA, Shelton RC, Fayanju OM, Ware S, Plag M, Hyland S, Gionta T, Shulman LN, Schnoll RImplementation science : ISProtocol for a pragmatic stepped wedge cluster randomized clinical trial testing behavioral economic implementation strategies to increase supplemental breast MRI screening among patients with extremely dense breasts. Implement Sci. 2023 Nov 24; 18(1):65.Implement Sci2023-11-24T00:00:002023Protocol for a pragmatic stepped wedge cluster randomized clinical trial testing behavioral economic implementation strategies to increase supplemental breast MRI screening among patients with extremely dense breasts.true1Professor of Medicine, EmeritusProfessor of Medicine, EmeritusAuthorship 1618654638176100Boffa DJ, Nelson H, Mullett T, Opelka F, Turner PL, Shulman LNJournal of the National Comprehensive Cancer Network : JNCCNPrivacy on the Road to Personalized Medicine. J Natl Compr Canc Netw. 2024 Jan; 22(1D):1-5.J Natl Compr Canc Netw2024-01-01T00:00:002024Privacy on the Road to Personalized Medicine.Authorship 16217801538237102Lau-Min KS, Marini J, Shah NK, Pucci D, Blauch AN, Cambareri C, Mooney B, Agarwal P, Johnston C, Schumacher RP, White K, Gabriel PE, Rosin R, Jacobs LA, Shulman LNJCO oncology practicePilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine. JCO Oncol Pract. 2024 Jan 18; OP2300365.JCO Oncol Pract2024-01-18T00:00:002024Pilot Study of a Mobile Phone Chatbot for Medication Adherence and Toxicity Management Among Patients With GI Cancers on Capecitabine.Authorship 16263909Authorship 1626365938296302Martei YM, Mokokwe L, Ngwako N, Kebuang K, Setlhako DI, Gabaatlhole G, Baaitse B, Segadimo T, Shulman LN, Barg F, Gaolebale BEBMJ openDevelopment, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study. BMJ Open. 2024 01 30; 14(1):e073867.BMJ Open2024-01-30T00:00:002024Development, acceptability and usability of culturally appropriate survivor narrative videos for breast cancer treatment in Botswana: a pilot study.38297294DeBoer RJ, Ho A, Mutoniwase E, Nguyen C, Umutesi G, Bigirimana JB, Nsabimana N, Van Loon K, Shulman LN, Triedman SA, Cubaka VK, Shyirambere CBMC medical ethicsEthical dilemmas in prioritizing patients for scarce radiotherapy resources. BMC Med Ethics. 2024 01 31; 25(1):12.BMC Med Ethics2024-01-31T00:00:002024Ethical dilemmas in prioritizing patients for scarce radiotherapy resources.Authorship 591136Authorship 174034true1Assistant Professor of MedicineAssistant Professor of Medicinetrue1Professor of MedicineProfessor of MedicineAuthorship 581707Authorship 596849Authorship 3137725Authorship 3327186Authorship 595599Authorship 599010Authorship 602264Authorship 609542Authorship 6370852Authorship 6484881Authorship 6448087Authorship 6519364Authorship 6518016Authorship 6669997Authorship 6406322Authorship 6562501Authorship 6559755Authorship 6603502Authorship 665719123714480LeBlanc TW, Shulman LN, Yu PP, Hirsch BR, Abernethy APAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingThe ethics of health information technology in oncology: emerging isssues from both local and global perspectives. Am Soc Clin Oncol Educ Book. 2013; 136-42.Am Soc Clin Oncol Educ Book2013-01-01T00:00:002013The ethics of health information technology in oncology: emerging isssues from both local and global perspectives.15579356Shulman L, Ost DCritical care clinicsManaging infection in the critical care unit: how can infection control make the ICU safe? Crit Care Clin. 2005 Jan; 21(1):111-28, ix.Crit Care Clin2005-01-01T00:00:002005Managing infection in the critical care unit: how can infection control make the ICU safe?23598852Weingart SN, Mattsson T, Zhu J, Shulman LN, Hassett MJournal of oncology practiceImproving electronic oral chemotherapy prescription: can we build a safer system? J Oncol Pract. 2012 Nov; 8(6):e168-73.J Oncol Pract2012-09-25T00:00:002012Improving electronic oral chemotherapy prescription: can we build a safer system?18339794Hwang D, Shakir N, Limann B, Sison C, Kalra S, Shulman L, Souza Ade C, Greenberg HChestAssociation of sleep-disordered breathing with postoperative complications. Chest. 2008 May; 133(5):1128-34.Chest2008-03-13T00:00:002008Association of sleep-disordered breathing with postoperative complications.23942490Shulman LN, Mamon H, Jacobson JO, Steingisser L, Dodek A, Fallon JAJournal of oncology practicePartnership between a cancer center and payer: opportunities for improved quality of care and cost reduction. J Oncol Pract. 2013 May; 9(3):133-4.J Oncol Pract2013-05-01T00:00:002013Partnership between a cancer center and payer: opportunities for improved quality of care and cost reduction.23597169Silva TB, Mauad EC, Carvalho AL, Jacobs LA, Shulman LNRural and remote healthDifficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods. Rural Remote Health. 2013 Apr-Jun; 13(2):2321.Rural Remote Health2013-04-18T00:00:002013Difficulties in implementing an organized screening program for breast cancer in Brazil with emphasis on diagnostic methods.15464103Sundaram R, Shulman L, Fein AMThe Medical clinics of North AmericaTrends in tobacco use. Med Clin North Am. 2004 Nov; 88(6):1391-7, ix.Med Clin North Am2004-11-01T00:00:002004Trends in tobacco use.23714553Shulman LNAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingEfficient and effective models for integrating advanced practice professionals into oncology practice. Am Soc Clin Oncol Educ Book. 2013.Am Soc Clin Oncol Educ Book2013-01-01T00:00:002013Efficient and effective models for integrating advanced practice professionals into oncology practice.16446250Sundaram R, Shulman L, Fein AMClinics in occupational and environmental medicineTrends in tobacco use. Clin Occup Environ Med. 2006; 5(1):1-7, vii.Clin Occup Environ Med2006-01-01T00:00:002006Trends in tobacco use.23175451Weingart SN, Cleary A, Scullion B, Morway L, Phantumvanit V, Stuver SO, Shulman LN, Connors JMJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy PractitionersComparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology. J Oncol Pharm Pract. 2013 Sep; 19(3):237-45.J Oncol Pharm Pract2012-11-21T00:00:002012Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology.23840209Sharma K, Costas A, Damuse R, Hamiltong-Pierre J, Pyda J, Ong CT, Shulman LN, Meara JGJournal of oncologyThe Haiti Breast Cancer Initiative: Initial Findings and Analysis of Barriers-to-Care Delaying Patient Presentation. J Oncol. 2013; 2013:206367.J Oncol2013-06-05T00:00:002013The Haiti Breast Cancer Initiative: Initial Findings and Analysis of Barriers-to-Care Delaying Patient Presentation.Authorship 751951Authorship 550304Authorship 69501836165297Revel M, Kimchi A, Shulman L, Fradin A, Shuster R, Yakobson E, Chernajovsky Y, Schmidt A, Shure A, Bendori RAnnals of the New York Academy of SciencesRole of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon. Ann N Y Acad Sci. 1980; 350:459-72.Ann N Y Acad Sci1980-01-01T00:00:001980Role of interferon-induced enzymes in the antiviral and antimitogenic effects of interferon.Authorship 257701Authorship 699139424358421Mtonga P, Masamba L, Milner D, Shulman LN, Nyirenda R, Mwafulirwa KMalawi medical journal : the journal of Medical Association of MalawiBiopsy case mix and diagnostic yield at a Malawian central hospital. Malawi Med J. 2013 Sep; 25(3):62-4.Malawi Med J2013-09-01T00:00:002013Biopsy case mix and diagnostic yield at a Malawian central hospital.Authorship 703118124406837Shulman LNNarrative inquiry in bioethicsBringing cancer care to those who don't have it. Narrat Inq Bioeth. 2012; 2(2):E10-2.Narrat Inq Bioeth2012-01-01T00:00:002012Bringing cancer care to those who don't have it.Authorship 2671285Authorship 290393324703831Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, Ngabo F, Wagner CM, Nutt CT, Nyatanyi T, Gatera M, Kayiteshonga Y, Mugeni C, Mugwaneza P, Shema J, Uwaliraye P, Gaju E, Muhimpundu MA, Dushime T, Senyana F, Mazarati JB, Gaju CM, Tuyisenge L, Mutabazi V, Kyamanywa P, Rusanganwa V, Nyemazi JP, Umutoni A, Kankindi I, Ntizimira C, Ruton H, Mugume N, Nkunda D, Ndenga E, Mubiligi JM, Kakoma JB, Karita E, Sekabaraga C, Rusingiza E, Rich ML, Mukherjee JS, Rhatigan J, Cancedda C, Bertrand-Farmer D, Bukhman G, Stulac SN, Tapela NM, van der Hoof Holstein C, Shulman LN, Habinshuti A, Bonds MH, Wilkes MS, Lu C, Smith-Fawzi MC, Swain JD, Murphy MP, Ricks A, Kerry VB, Bush BP, Siegler RW, Stern CS, Sliney A, Nuthulaganti T, Karangwa I, Pegurri E, Dahl O, Drobac PCLancet (London, England)Rwanda 20 years on: investing in life. Lancet. 2014 Jul 26; 384(9940):371-5.Lancet2014-04-04T00:00:002014Rwanda 20 years on: investing in life.Authorship 1985723Authorship 2023804Authorship 2478914Authorship 731775124857141Shulman LNAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingThe effect of accountable care organizations on oncology practice. Am Soc Clin Oncol Educ Book. 2014; e468-71.Am Soc Clin Oncol Educ Book2014-01-01T00:00:002014The effect of accountable care organizations on oncology practice.Authorship 7395131924994917Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DAJournal of the National Comprehensive Cancer Network : JNCCNOccult primary, version 3.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):969-74.J Natl Compr Canc Netw2014-07-01T00:00:002014Occult primary, version 3.2014.Authorship 3143696Authorship 2806435Authorship 4457092Authorship 3974857Authorship 74638015Authorship 7469001Authorship 7475402Authorship 7535044924513692Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DLThe pharmacogenomics journalPolygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J. 2014 Aug; 14(4):336-42.Pharmacogenomics J2014-02-11T00:00:002014Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance).24934787Shulman LN, Berry DA, Cirrincione CT, Becker HP, Perez EA, O'Regan R, Martino S, Shapiro CL, Schneider CJ, Kimmick G, Burstein HJ, Norton L, Muss H, Hudis CA, Winer EPJournal of clinical oncology : official journal of the American Society of Clinical OncologyComparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance). J Clin Oncol. 2014 Aug 01; 32(22):2311-7.J Clin Oncol2014-06-16T00:00:002014Comparison of doxorubicin and cyclophosphamide versus single-agent paclitaxel as adjuvant therapy for breast cancer in women with 0 to 3 positive axillary nodes: CALGB 40101 (Alliance).15203412Shedlin MG, Shulman LAIDS careQualitative needs assessment of HIV services among Dominican, Mexican and Central American immigrant populations living in the New York City area. AIDS Care. 2004 May; 16(4):434-45.AIDS Care2004-05-01T00:00:002004Qualitative needs assessment of HIV services among Dominican, Mexican and Central American immigrant populations living in the New York City area.Authorship 7585691325232190Steingisser L, Acker B, Berman S, Brenner MJ, Bornstein BA, Busse P, FitzGerald TJ, Jacobson JO, Jekowsky E, Kachnic LA, Mamon H, McKee A, Shulman LN, Stevenson MA, Wazer D, Fallon JAJournal of oncology practiceBending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology. J Oncol Pract. 2014 Sep; 10(5):e321-7.J Oncol Pract2014-09-01T00:00:002014Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology.2014-07-25T00:00:002014-06-16T00:00:00Assessing Palliative Care Needs of Oncology Patients in Mirebalais, HaitiSummerAuthorship 591826Authorship 595383Authorship 2144251Authorship 3453295Authorship 36045622014-09-09T00:00:002014-06-01T00:00:00Towards a Simple Oncology Electronic Health Record for Low and Middle Income Countries: Lessons from Zanmi Lasante in Mirebalais, HaitiSummerAuthorship 7612911025239422Mpunga T, Tapela N, Hedt-Gauthier BL, Milner D, Nshimiyimana I, Muvugabigwi G, Moore M, Shulman DS, Pepoon JR, Shulman LNAmerican journal of clinical pathologyDiagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settings. Am J Clin Pathol. 2014 Oct; 142(4):541-5.Am J Clin Pathol2014-10-01T00:00:002014Diagnosis of cancer in rural Rwanda: early outcomes of a phased approach to implement anatomic pathology services in resource-limited settings.Authorship 3760086Authorship 7621921025285973Glaser MS, Shah N, Webber MP, Zeig-Owens R, Jaber N, Appel DW, Hall CB, Weakley J, Cohen HW, Shulman L, Kelly K, Prezant DJournal of occupational and environmental medicineObstructive sleep apnea and World Trade Center exposure. J Occup Environ Med. 2014 Oct; 56 Suppl 10:S30-4.J Occup Environ Med2014-10-01T00:00:002014Obstructive sleep apnea and World Trade Center exposure.Authorship 3996987Authorship 41528514Authorship 41955452014-08-02T00:00:002014-06-09T00:00:00Evaluation of Clinical Tool for Tracking Chemotherapy Completion, Associated Toxicities and Related Adverse Events in Butaro, RwandaInternationalAuthorship 66001Authorship 770402625316025Mayer DK, Nekhlyudov L, Snyder CF, Merrill JK, Wollins DS, Shulman LNJournal of oncology practiceAmerican Society of Clinical Oncology clinical expert statement on cancer survivorship care planning. J Oncol Pract. 2014 Nov; 10(6):345-51.J Oncol Pract2014-10-14T00:00:002014American Society of Clinical Oncology clinical expert statement on cancer survivorship care planning.Authorship 771502125355378Shulman LN, Mpunga T, Tapela N, Wagner CM, Fadelu T, Binagwaho ANature reviews. CancerBringing cancer care to the poor: experiences from Rwanda. Nat Rev Cancer. 2014 12; 14(12):815-21.Nat Rev Cancer2014-10-30T00:00:002014Bringing cancer care to the poor: experiences from Rwanda.Authorship 4410763Authorship 772137625071121Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, Martino S, Wang M, Jones VE, Saphner TJ, Wolff AC, Wood WC, Davidson NE, Sledge GW, Sparano JA, Badve SSJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol. 2014 Sep 20; 32(27):2959-66.J Clin Oncol2014-09-20T00:00:002014Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.Authorship 4697051Authorship 775114825478326Coleman CN, Formenti SC, Williams TR, Petereit DG, Soo KC, Wong J, Chao N, Shulman LN, Grover S, Magrath I, Hahn S, Liu FF, DeWeese T, Khleif SN, Steinberg M, Roth L, Pistenmaa DA, Love RR, Mohiuddin M, Vikram BFrontiers in oncologyThe international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries. Front Oncol. 2014; 4:333.Front Oncol2014-11-19T00:00:002014The international cancer expert corps: a unique approach for sustainable cancer care in low and lower-middle income countries.Authorship 4971591Authorship 5038544Authorship 608970Authorship 25401816Authorship 5684816Authorship 580331Authorship 586099Authorship 615108Authorship 960615Authorship 604797Authorship 609079Authorship 623927Authorship 433414Authorship 4699883Authorship 4920023Authorship 4581926Authorship 377162Authorship 5313698Authorship 3832161Authorship 547692Authorship 5768039Authorship 587590Authorship 5696809Authorship 590968Authorship 4118195Authorship 602675Authorship 5742876Authorship 626011Authorship 604458Authorship 870481Authorship 2651963Authorship 2918281Authorship 2044395Authorship 3067365Authorship 3000741Authorship 3016984Authorship 3207466Authorship 3900555Authorship 2561436Authorship 2178348Authorship 621370Authorship 662373Authorship 25915017Authorship 2748836Authorship 4230941Authorship 2291232Authorship 3172171Authorship 3225245Authorship 409005Authorship 5045077Authorship 5423725Authorship 7888269Authorship 7855231Authorship 8053164Authorship 7963811Authorship 7970441Authorship 8016371Authorship 80126162333830Shulman L, Miller JL, Rose LIAmerican family physicianGrowth hormone therapy. Am Fam Physician. 1990 May; 41(5):1541-6.Am Fam Physician1990-05-01T00:00:001990Growth hormone therapy.25512457Shulman LN, Berry DA, Cirrincione CT, Hudis CA, Winer EPJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to V. Amoroso et al. J Clin Oncol. 2015 Jan 20; 33(3):291.J Clin Oncol2014-12-15T00:00:002014Reply to V. Amoroso et al.25824792Son BH, Dominici LS, Aydogan F, Shulman LN, Ahn SH, Cho JY, Coopey SB, Kim SB, Min HE, Valero M, Wang J, Caragacianu D, Gong GY, Hevelone ND, Baek S, Golshan MAsian Pacific journal of cancer prevention : APJCPYoung women with breast cancer in the United States and South Korea: comparison of demographics, pathology and management. Asian Pac J Cancer Prev. 2015; 16(6):2531-5.Asian Pac J Cancer Prev2015-01-01T00:00:002015Young women with breast cancer in the United States and South Korea: comparison of demographics, pathology and management.25901051Shulman LN, McCabe R, Gay G, Palis B, McKellar DJournal of oncology practiceBuilding Data Infrastructure to Evaluate and Improve Quality: The National Cancer Data Base and the Commission on Cancer's Quality Improvement Programs. J Oncol Pract. 2015 May; 11(3):209-12.J Oncol Pract2015-04-21T00:00:002015Building Data Infrastructure to Evaluate and Improve Quality: The National Cancer Data Base and the Commission on Cancer's Quality Improvement Programs.25905040Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SMFrontiers in oncologyTraining global oncologists: addressing the global cancer control problem. Front Oncol. 2015; 5:80.Front Oncol2015-04-08T00:00:002015Training global oncologists: addressing the global cancer control problem.25604811Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Ambinder EPJournal of the American Medical Informatics Association : JAMIADevelopment, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization. J Am Med Inform Assoc. 2015 May; 22(3):577-86.J Am Med Inform Assoc2015-01-20T00:00:002015Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization.25993194Shulman LNAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingCancer care quality: current state and future directions. Am Soc Clin Oncol Educ Book. 2015; e337-41.Am Soc Clin Oncol Educ Book2015-01-01T00:00:002015Cancer care quality: current state and future directions.Authorship 587968Authorship 609289Authorship 616553Authorship 2995254Authorship 3776227Authorship 4241491Authorship 4625191Authorship 5282897Authorship 5347656Authorship 4363846Authorship 4558463Authorship 465374Authorship 80845910Authorship 8090821226032138Pace LE, Mpunga T, Hategekimana V, Dusengimana JM, Habineza H, Bigirimana JB, Mutumbira C, Mpanumusingo E, Ngiruwera JP, Tapela N, Amoroso C, Shulman LN, Keating NLThe oncologistDelays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda. Oncologist. 2015 Jul; 20(7):780-8.Oncologist2015-06-01T00:00:002015Delays in Breast Cancer Presentation and Diagnosis at Two Rural Cancer Referral Centers in Rwanda.26114095Grover S, Balogun OD, Yamoah K, Groen R, Shah M, Rodin D, Martei Y, Olson AC, Slone JS, Shulman LN, Coleman CN, Hahn SMFrontiers in oncologyCorrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem". Front Oncol. 2015; 5:133.Front Oncol2015-06-10T00:00:002015Corrigendum: "Training Global Oncologists: Addressing the Global Cancer Control Problem".Authorship 38529214Authorship 8227901226248848Stulac S, Binagwaho A, Tapela NM, Wagner CM, Muhimpundu MA, Ngabo F, Nsanzimana S, Kayonde L, Bigirimana JB, Lessard AJ, Lehmann L, Shulman LN, Nutt CT, Drobac P, Mpunga T, Farmer PEThe Lancet. OncologyCapacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience. Lancet Oncol. 2015 Aug; 16(8):e405-13.Lancet Oncol2015-08-01T00:00:002015Capacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience.Authorship 825127825924837Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LNLancet (London, England)Surgical palliative care in resource-limited settings. Lancet. 2015 Aug 08; 386(9993):527.Lancet2015-04-27T00:00:002015Surgical palliative care in resource-limited settings.Authorship 4646366Authorship 4964476Authorship 51310311Authorship 5384465Authorship 5589413Authorship 8376471126399213Mubiligi JM, Hedt-Gauthier B, Mpunga T, Tapela N, Okao P, Harries AD, Edginton ME, Driscoll C, Mugabo L, Riviello R, Shulman LNPublic health actionCaring for patients with surgically resectable cancers: experience from a specialised centre in rural Rwanda. Public Health Action. 2014 Jun 21; 4(2):128-32.Public Health Action2014-06-21T00:00:002014Caring for patients with surgically resectable cancers: experience from a specialised centre in rural Rwanda.Authorship 840530526460990Olson AC, Coleman CN, Hahn SM, DeWeese TL, Shulman LN, Chabner BA, Chao N, Martei YM, Mundt AJ, Grover SInternational journal of radiation oncology, biology, physicsA Roadmap for a New Academic Pathway for Global Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):493-6.Int J Radiat Oncol Biol Phys2015-11-01T00:00:002015A Roadmap for a New Academic Pathway for Global Radiation Oncology.Authorship 4585433Authorship 846972426209571Mallin K, Loomis AM, Palis B, Shulman LN, Winchester DPSurgeryRegarding 'Opportunity lost: Adjuvant chemotherapy in patients with Stage III colon cancer remains underused'. Surgery. 2015 Dec; 158(6):1745-6.Surgery2015-07-21T00:00:002015Regarding 'Opportunity lost: Adjuvant chemotherapy in patients with Stage III colon cancer remains underused'.Authorship 8554651Authorship 85557913Authorship 855042126578613Shulman LN, Wagner CM, Barr R, Lopes G, Longo G, Robertson J, Forte G, Torode J, Magrini NJournal of clinical oncology : official journal of the American Society of Clinical OncologyProposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes. J Clin Oncol. 2016 Jan 01; 34(1):69-75.J Clin Oncol2015-11-17T00:00:002015Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes.26578617Tapela NM, Mpunga T, Karema N, Nzayisenga I, Fadelu T, Uwizeye FR, Hirschhorn LR, Muhimpundu MA, Balinda JP, Amoroso C, Wagner CM, Binagwaho A, Shulman LNJournal of clinical oncology : official journal of the American Society of Clinical OncologyImplementation Science for Global Oncology: The Imperative to Evaluate the Safety and Efficacy of Cancer Care Delivery. J Clin Oncol. 2016 Jan 01; 34(1):43-52.J Clin Oncol2015-11-17T00:00:002015Implementation Science for Global Oncology: The Imperative to Evaluate the Safety and Efficacy of Cancer Care Delivery.26578609Shulman LN, Mok TSJournal of clinical oncology : official journal of the American Society of Clinical OncologySpecial Issue on Global Cancer Medicine. J Clin Oncol. 2016 01 01; 34(1):1-2.J Clin Oncol2015-11-17T00:00:002015Special Issue on Global Cancer Medicine.Authorship 515622Authorship 55277111Authorship 5802472015-08-20T00:00:002015-06-05T00:00:00“Ou Menm Ak Kansè”: Developing an Educational Booklet for Patients with Cancer in HaitiSummerAuthorship 587727Authorship 623461Authorship 865497326869653Evans TL, Gabriel PE, Shulman LNJournal of oncology practiceCancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data. J Oncol Pract. 2016 Feb; 12(2):137-9.J Oncol Pract2016-02-01T00:00:002016Cancer Staging in Electronic Health Records: Strategies to Improve Documentation of These Critical Data.Authorship 8729409Authorship 8731562026992690Tapela NM, Mpunga T, Hedt-Gauthier B, Moore M, Mpanumusingo E, Xu MJ, Nzayisenga I, Hategekimana V, Umuhizi DG, Pace LE, Bigirimana JB, Wang J, Driscoll C, Uwizeye FR, Drobac PC, Ngoga G, Shyirambere C, Muhayimana C, Lehmann L, Shulman LNBMC cancerPursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda. BMC Cancer. 2016 Mar 18; 16:237.BMC Cancer2016-03-18T00:00:002016Pursuing equity in cancer care: implementation, challenges and preliminary findings of a public cancer referral center in rural Rwanda.26785111Stulac S, Mark Munyaneza RB, Chai J, Bigirimana JB, Nyishime M, Tapela N, Chaffee S, Lehmann L, Shulman LNPediatric blood & cancerInitiating Childhood Cancer Treatment in Rural Rwanda: A Partnership-Based Approach. Pediatr Blood Cancer. 2016 May; 63(5):813-7.Pediatr Blood Cancer2016-01-19T00:00:002016Initiating Childhood Cancer Treatment in Rural Rwanda: A Partnership-Based Approach.Authorship 3845443Authorship 4306317Authorship 8815931427009935Pace LE, Dusengimana JM, Hategekimana V, Habineza H, Bigirimana JB, Tapela N, Mutumbira C, Mpanumusingo E, Brock JE, Meserve E, Uwumugambi A, Dillon D, Keating NL, Shulman LN, Mpunga TThe oncologistBenign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center. Oncologist. 2016 05; 21(5):571-5.Oncologist2016-03-23T00:00:002016Benign and Malignant Breast Disease at Rwanda's First Public Cancer Referral Center.Authorship 5349266Authorship 884632427249686Ruff P, Al-Sukhun S, Blanchard C, Shulman LNAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingAccess to Cancer Therapeutics in Low- and Middle-Income Countries. Am Soc Clin Oncol Educ Book. 2016; 35:58-65.Am Soc Clin Oncol Educ Book2016-01-01T00:00:002016Access to Cancer Therapeutics in Low- and Middle-Income Countries.Authorship 886287127161967Shulman LN, Wagner CM, Torode JJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to D.W. Felsher et al. J Clin Oncol. 2016 06 20; 34(18):2195.J Clin Oncol2016-05-09T00:00:002016Reply to D.W. Felsher et al.Authorship 589720Authorship 888203227091419Pace LE, Shulman LNThe oncologistBreast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality. Oncologist. 2016 06; 21(6):739-44.Oncologist2016-04-18T00:00:002016Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.Authorship 5864422Assistant Professor1Associate Professor0Full Professor4Instructor3LecturerAuthorship 626727Authorship 581557Authorship 4911542Authorship 5678413Authorship 703845Authorship 48453210Authorship 908361727334212Miller ME, Kyrillos A, Yao K, Kantor O, Tseng J, Winchester DJ, Shulman LNAnnals of surgical oncologyUtilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base. Ann Surg Oncol. 2016 10; 23(10):3337-46.Ann Surg Oncol2016-06-22T00:00:002016Utilization of Axillary Surgery for Patients With Ductal Carcinoma In Situ: A Report From the National Cancer Data Base.Authorship 599288Authorship 617968Authorship 9122917Authorship 913274127597289Bauml JM, Troxel A, Epperson CN, Cohen RB, Schmitz K, Stricker C, Shulman LN, Bradbury A, Mao JJ, Langer CJLung cancer (Amsterdam, Netherlands)Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung Cancer. 2016 10; 100:110-113.Lung Cancer2016-08-16T00:00:002016Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".25424651Shulman LN, Ferris L, Takanishi DM, McKellar DJournal of oncology practiceTreatment Summaries and Survivorship Care Plans: The Approach by the Commission on Cancer to Increase Use. J Oncol Pract. 2015 01; 11(1):40-1.J Oncol Pract2014-11-25T00:00:002014Treatment Summaries and Survivorship Care Plans: The Approach by the Commission on Cancer to Increase Use.Authorship 945877Authorship 95767Authorship 9226121119996222Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez E, Shulman LN, Martino S, Davidson NE, Sledge GW, Gray RClinical cancer research : an official journal of the American Association for Cancer ResearchRelationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer. Clin Cancer Res. 2009 Dec 15; 15(24):7693-7700.Clin Cancer Res2009-12-15T00:00:002009Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer.Authorship 46022733Authorship 9360113Authorship 9343211727866278Freedman RA, Seisler DK, Foster JC, Sloan JA, Lafky JM, Kimmick GG, Hurria A, Cohen HJ, Winer EP, Hudis CA, Partridge AH, Carey LA, Jatoi A, Klepin HD, Citron M, Berry DA, Shulman LN, Buzdar AU, Suman VJ, Muss HBBreast cancer research and treatmentRisk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511). Breast Cancer Res Treat. 2017 01; 161(2):363-373.Breast Cancer Res Treat2016-11-19T00:00:002016Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511).27843163Robertson J, Barr R, Shulman LN, Forte GB, Magrini NBulletin of the World Health OrganizationEssential medicines for cancer: WHO recommendations and national priorities. Bull World Health Organ. 2016 Oct 01; 94(10):735-742.Bull World Health Organ2016-07-05T00:00:002016Essential medicines for cancer: WHO recommendations and national priorities.Authorship 581180Authorship 584312Authorship 593380Authorship 599312Authorship 618726Authorship 623728Authorship 4150762Authorship 945468328022502Beckjord EB, Rechis R, Shulman LN, Hesse BJournal of clinical oncology : official journal of the American Society of Clinical OncologyPerspectives on electronic health information exchange among people affected by cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):6123.J Clin Oncol2011-05-20T00:00:002011Perspectives on electronic health information exchange among people affected by cancer.Authorship 947602228049574Jacobs LA, Shulman LNThe Lancet. OncologyFollow-up care of cancer survivors: challenges and solutions. Lancet Oncol. 2017 01; 18(1):e19-e29.Lancet Oncol2017-01-01T00:00:002017Follow-up care of cancer survivors: challenges and solutions.Authorship 952305427979711Liu JB, Huffman KM, Palis BE, Shulman LN, Winchester DP, Ko CY, Hall BLJournal of the American College of SurgeonsReliability of the American College of Surgeons Commission on Cancer's Quality of Care Measures for Hospital and Surgeon Profiling. J Am Coll Surg. 2017 Feb; 224(2):180-190.e8.J Am Coll Surg2016-12-12T00:00:002016Reliability of the American College of Surgeons Commission on Cancer's Quality of Care Measures for Hospital and Surgeon Profiling.Authorship 9556241Authorship 9550385Authorship 9545891628147072Buswell LA, Amorati M, Arthur L, Bernard A, Constantine M, Dalby C, Farrar W, Fuller F, Kerivan D, Lacourse K, McNulty BD, Racicot A, Spinks M, Jacobson JO, Ponte PR, Shulman LNJournal of clinical oncology : official journal of the American Society of Clinical OncologyWait time reduction for patients awaiting chemotherapy infusion using a formal process improvement approach and sequential. J Clin Oncol. 2012 Dec; 30(34_suppl):92.J Clin Oncol2012-12-01T00:00:002012Wait time reduction for patients awaiting chemotherapy infusion using a formal process improvement approach and sequential.28136255Dalby CK, Anastas S, Brady L, Hassett MJ, Shulman LN, Jacobson JOJournal of clinical oncology : official journal of the American Society of Clinical OncologyImplementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing. J Clin Oncol. 2013 Nov; 31(31_suppl):20.J Clin Oncol2013-11-01T00:00:002013Implementation of chemotherapy treatment plans (CTP) in a large comprehensive cancer center (CCC): The key roles of infrastructure and data sharing.28152690Shulman LN, Jacobson JO, Norden ADJournal of clinical oncology : official journal of the American Society of Clinical OncologyMolecular testing for colorectal and lung cancer at an academic cancer center satellite site: Opportunities for improvement. J Clin Oncol. 2016 Mar; 34(7_suppl):229.J Clin Oncol2016-03-01T00:00:002016Molecular testing for colorectal and lung cancer at an academic cancer center satellite site: Opportunities for improvement.8993518Eder JP, Rubin E, Stone R, Bryant M, Xu G, Supko J, Kinchla N, Lynch T, Hurwitz S, Rodriguez D, Shapiro C, Toppmeyer D, Grossbard M, Vosburg E, Huberman M, Schnipper L, Shulman L, Kufe DWAnnals of the New York Academy of SciencesTrials of 9-amino-20(S)-camptothecin in Boston. Ann N Y Acad Sci. 1996 Dec 13; 803:247-55.Ann N Y Acad Sci1996-12-13T00:00:001996Trials of 9-amino-20(S)-camptothecin in Boston.9193363Janicek M, Kaplan W, Neuberg D, Canellos GP, Shulman LN, Shipp MAJournal of clinical oncology : official journal of the American Society of Clinical OncologyEarly restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy. J Clin Oncol. 1997 Apr; 15(4):1631-7.J Clin Oncol1997-04-01T00:00:001997Early restaging gallium scans predict outcome in poor-prognosis patients with aggressive non-Hodgkin's lymphoma treated with high-dose CHOP chemotherapy.9663416Smith D, Shaffer K, Kirn D, Canellos GP, Mauch PM, Shulman LNOncologyMediastinal large cell lymphoma: prognostic significance of CT findings at presentation and after treatment. Oncology. 1998 Jul-Aug; 55(4):284-8.Oncology1998-07-01T00:00:001998Mediastinal large cell lymphoma: prognostic significance of CT findings at presentation and after treatment.10555503Gray RR, Sadler DJ, Shulman L, Saliken JC, So CBCanadian Association of Radiologists journal = Journal l'Association canadienne des radiologistesShould anticoagulant therapy be stopped or reversed before venous intervention? Can Assoc Radiol J. 1999 Oct; 50(5):306-9.Can Assoc Radiol J1999-10-01T00:00:001999Should anticoagulant therapy be stopped or reversed before venous intervention?11707832Jacobson JO, Grossbard M, Shulman LN, Neuberg DClinical lymphomaCHOP chemotherapy with preemptive granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma: a dose-intensity analysis. Clin Lymphoma. 2000 Dec; 1(3):211-7; discussion 218.Clin Lymphoma2000-12-01T00:00:002000CHOP chemotherapy with preemptive granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma: a dose-intensity analysis.11896105Vasey PA, Shulman LN, Campos S, Davis J, Gore M, Johnston S, Kirn DH, O'Neill V, Siddiqui N, Seiden MV, Kaye SBJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol. 2002 Mar 15; 20(6):1562-9.J Clin Oncol2002-03-15T00:00:002002Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer.Authorship 9644375Authorship 963870627946381Goldstein LJ, O'Neill A, Sparano J, Perez E, Shulman L, Martino S, Davidson NJournal of clinical oncology : official journal of the American Society of Clinical OncologyE2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer. J Clin Oncol. 2005 Jun; 23(16_suppl):512.J Clin Oncol2005-06-01T00:00:002005E2197: Phase III AT (doxorubicin/docetaxel) vs. AC (doxorubicin/cyclophosphamide) in the adjuvant treatment of node positive and high risk node negative breast cancer.27459331Ruddy KJ, Guo H, Baker EL, Goldstein MJ, Mullaney EE, Shulman LN, Partridge AHCancerRandomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016 Nov 15; 122(22):3546-3554.Cancer2016-07-26T00:00:002016Randomized phase 2 trial of a coordinated breast cancer follow-up care program.10571193Dubey A, Recht A, Come SE, Gelman RS, Silver B, Harris JR, Shulman LNInternational journal of radiation oncology, biology, physicsConcurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study. Int J Radiat Oncol Biol Phys. 1999 Nov 01; 45(4):877-84.Int J Radiat Oncol Biol Phys1999-11-01T00:00:001999Concurrent CMF and radiation therapy for early stage breast cancer: results of a pilot study.10593239Shulman L, Mahallati H, Gray RCanadian journal of surgery. Journal canadien de chirurgieSoft-tissue case 30. Presentation. Pelvic trauma: detection of active bleeding by computed tomography. Can J Surg. 1999 Dec; 42(6):413, 420.Can J Surg1999-12-01T00:00:001999Soft-tissue case 30. Presentation. Pelvic trauma: detection of active bleeding by computed tomography.10813714Sternberg DW, Aird W, Neuberg D, Thompson L, MacNeill K, Amrein P, Shulman LNCancerTreatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen. Cancer. 2000 May 01; 88(9):2037-41.Cancer2000-05-01T00:00:002000Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.9294468Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PMJournal of clinical oncology : official journal of the American Society of Clinical OncologyClinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. J Clin Oncol. 1997 Sep; 15(9):3060-6.J Clin Oncol1997-09-01T00:00:001997Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.9308940Hughes-Davies L, Tarbell NJ, Coleman CN, Silver B, Shulman LN, Linggood R, Canellos GP, Mauch PMInternational journal of radiation oncology, biology, physicsStage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement. Int J Radiat Oncol Biol Phys. 1997 Sep 01; 39(2):361-9.Int J Radiat Oncol Biol Phys1997-09-01T00:00:001997Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.9469331Gage I, Schnitt SJ, Recht A, Abner A, Come S, Shulman LN, Monson JM, Silver B, Harris JR, Connolly JLJournal of clinical oncology : official journal of the American Society of Clinical OncologySkin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol. 1998 Feb; 16(2):480-6.J Clin Oncol1998-02-01T00:00:001998Skin recurrences after breast-conserving therapy for early-stage breast cancer.Authorship 9669941028241198Boffa DJ, Rosen JE, Mallin K, Loomis A, Gay G, Palis B, Thoburn K, Gress D, McKellar DP, Shulman LN, Facktor MA, Winchester DPJAMA oncologyUsing the National Cancer Database for Outcomes Research: A Review. JAMA Oncol. 2017 12 01; 3(12):1722-1728.JAMA Oncol2017-12-01T00:00:002017Using the National Cancer Database for Outcomes Research: A Review.9452275Bunnell CA, Thompson L, Buswell L, Berkowitz R, Muto M, Sheets E, Shulman LNCancerA Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors. Cancer. 1998 Feb 01; 82(3):561-6.Cancer1998-02-01T00:00:001998A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.11595121Shulman LNCurrent oncology reportsWhat is the ideal duration of adjuvant therapy for primary breast cancer: are four cycles of cyclophosphamide and doxorubicin enough? Curr Oncol Rep. 2001 Nov; 3(6):523-8.Curr Oncol Rep2001-11-01T00:00:002001What is the ideal duration of adjuvant therapy for primary breast cancer: are four cycles of cyclophosphamide and doxorubicin enough?15042668Bellon JR, Shulman LN, Come SE, Li X, Gelman RS, Silver BJ, Harris JR, Recht ACancerA prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer. 2004 Apr 01; 100(7):1358-64.Cancer2004-04-01T00:00:002004A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma.9516917Eder JP, Supko JG, Lynch T, Bryant M, Vosburgh E, Shulman LN, Xu G, Kufe DWClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion. Clin Cancer Res. 1998 Feb; 4(2):317-24.Clin Cancer Res1998-02-01T00:00:001998Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion.12228197Eder JP, Supko JG, Clark JW, Puchalski TA, Garcia-Carbonero R, Ryan DP, Shulman LN, Proper J, Kirvan M, Rattner B, Connors S, Keogan MT, Janicek MJ, Fogler WE, Schnipper L, Kinchla N, Sidor C, Phillips E, Folkman J, Kufe DWJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol. 2002 Sep 15; 20(18):3772-84.J Clin Oncol2002-09-15T00:00:002002Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.9928562Dubey AK, Recht A, Come S, Shulman L, Harris JRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancerWhy and how to combine chemotherapy and radiation therapy in breast cancer patients. Recent Results Cancer Res. 1998; 152:247-54.Recent Results Cancer Res1998-01-01T00:00:001998Why and how to combine chemotherapy and radiation therapy in breast cancer patients.Authorship 978160328426846Martei YM, Binagwaho A, Shulman LNJAMA oncologyAffordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life. JAMA Oncol. 2017 10 01; 3(10):1301-1302.JAMA Oncol2017-10-01T00:00:002017Affordability of Cancer Drugs in Sub-Saharan Africa: Effects of Pricing on Needless Loss of Life.9869237Shulman LN, Tarbell NJ, Storen E, Marcus K, Mauch PMInternational journal of radiation oncology, biology, physicsLow-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1113-7.Int J Radiat Oncol Biol Phys1998-12-01T00:00:001998Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission.10124510Kaye JA, Shulman LNHMO practiceScreening program for colorectal cancer: effect on stage distribution. HMO Pract. 1992 Sep; 6(3):13-5.HMO Pract1992-09-01T00:00:001992Screening program for colorectal cancer: effect on stage distribution.Shulman LN. Mason DY and Harris NL, eds. Human lymphoma: clniical implications of the REAL classification.Is anaplastic large cell lymphoma (ALCL) clinically distinct from diffuse large B cell lymphoma?. Mason DY and Harris NL, eds. Human lymphoma: clniical implications of the REAL classification. 1999; 39:0-7.1999-01-01T00:00:001999Is anaplastic large cell lymphoma (ALCL) clinically distinct from diffuse large B cell lymphoma?Lukanich JM, Sugarbaker DJ, Shulman LN.Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast.Malignant effusions.
. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2004; 1261-72.2004-01-01T00:00:002004Malignant effusions.
12562654Canellos GP, Gollub J, Neuberg D, Mauch P, Shulman LNAnnals of oncology : official journal of the European Society for Medical OncologyPrimary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up. Ann Oncol. 2003 Feb; 14(2):268-72.Ann Oncol2003-02-01T00:00:002003Primary systemic treatment of advanced Hodgkin's disease with EVA (etoposide, vinblastine, doxorubicin): 10-year follow-up.11352965Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EPJournal of clinical oncology : official journal of the American Society of Clinical OncologyClinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer. J Clin Oncol. 2001 May 15; 19(10):2722-30.J Clin Oncol2001-05-15T00:00:002001Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.17223629Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor MBMJ (Clinical research ed.)Oral chemotherapy safety practices at US cancer centres: questionnaire survey. BMJ. 2007 Feb 24; 334(7590):407.BMJ2007-01-12T00:00:002007Oral chemotherapy safety practices at US cancer centres: questionnaire survey.Shulman LN.Am J Oncol RevChemotherapy in the treatment of patients with metastatic breast cancer: High-dose, low-dose - What have we accomplished? (commentary). Am J Oncol Rev. 2002; 1:169-70.2002-01-01T00:00:002002Chemotherapy in the treatment of patients with metastatic breast cancer: High-dose, low-dose - What have we accomplished? (commentary)16245353Gandhi TK, Bartel SB, Shulman LN, Verrier D, Burdick E, Cleary A, Rothschild JM, Leape LL, Bates DWCancerMedication safety in the ambulatory chemotherapy setting. Cancer. 2005 Dec 01; 104(11):2477-83.Cancer2005-12-01T00:00:002005Medication safety in the ambulatory chemotherapy setting.Authorship 986029428561681Eniu AE, Martei YM, Trimble EL, Shulman LNAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingCancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field. Am Soc Clin Oncol Educ Book. 2017; 37:409-415.Am Soc Clin Oncol Educ Book2017-01-01T00:00:002017Cancer Care and Control as a Human Right: Recognizing Global Oncology as an Academic Field.9339934Dees EC, Shulman LN, Souba WW, Smith BLAnnals of surgeryDoes information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg. 1997 Sep; 226(3):279-86; discussion 286-7.Ann Surg1997-09-01T00:00:001997Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection.17235046Rusch VW, Giroux DJ, Kraut MJ, Crowley J, Hazuka M, Winton T, Johnson DH, Shulman L, Shepherd F, Deschamps C, Livingston RB, Gandara DJournal of clinical oncology : official journal of the American Society of Clinical OncologyInduction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol. 2007 Jan 20; 25(3):313-8.J Clin Oncol2007-01-20T00:00:002007Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).16525651Balogh GA, Mailo DA, Corte MM, Roncoroni P, Nardi H, Vincent E, Martinez D, Cafasso ME, Frizza A, Ponce G, Vincent E, Barutta E, Lizarraga P, Lizarraga G, Monti C, Paolillo E, Vincent R, Quatroquio R, Grimi C, Maturi H, Aimale M, Spinsanti C, Montero H, Santiago J, Shulman L, Rivadulla M, Machiavelli M, Salum G, Cuevas MA, Picolini J, Gentili A, Gentili R, Mordoh JInternational journal of oncologyMutant p53 protein in serum could be used as a molecular marker in human breast cancer. Int J Oncol. 2006 Apr; 28(4):995-1002.Int J Oncol2006-04-01T00:00:002006Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.1846768Wheeler CA, Shulman LN, Ervin T, Come SE, Schnipper LECancerCisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung. Cancer. 1991 Feb 15; 67(4):892-5.Cancer1991-02-15T00:00:001991Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung.9194034Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini EH, Frei E, Sugarbaker DJLung cancer (Amsterdam, Netherlands)Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC). Lung Cancer. 1997 May; 17(1):147-61.Lung Cancer1997-05-01T00:00:001997Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).11301218Shinnar S, Rapin I, Arnold S, Tuchman RF, Shulman L, Ballaban-Gil K, Maw M, Deuel RK, Volkmar FRPediatric neurologyLanguage regression in childhood. Pediatr Neurol. 2001 Mar; 24(3):183-9.Pediatr Neurol2001-03-01T00:00:002001Language regression in childhood.19898229Carlson JW, Lyon E, Walton D, Foo WC, Sievers AC, Shulman LN, Farmer P, Nosé V, Milner DAThe American journal of surgical pathologyPartners in pathology: a collaborative model to bring pathology to resource poor settings. Am J Surg Pathol. 2010 Jan; 34(1):118-23.Am J Surg Pathol2010-01-01T00:00:002010Partners in pathology: a collaborative model to bring pathology to resource poor settings.20225328Weingart SN, Toro J, Spencer J, Duncombe D, Gross A, Bartel S, Miransky J, Partridge A, Shulman LN, Connor MCancerMedication errors involving oral chemotherapy. Cancer. 2010 May 15; 116(10):2455-64.Cancer2010-05-15T00:00:002010Medication errors involving oral chemotherapy.22826271Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis CJournal of clinical oncology : official journal of the American Society of Clinical OncologySix cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. J Clin Oncol. 2012 Nov 20; 30(33):4071-6.J Clin Oncol2012-07-23T00:00:002012Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101.2992644Groopman JE, Hartzband PI, Shulman L, Salahuddin SZ, Sarngadharan MG, McLane MF, Essex M, Gallo RBloodAntibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood. 1985 Sep; 66(3):742-4.Blood1985-09-01T00:00:001985Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders.Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, Shulman LN, Harris JR.N Engl J MedFive-year results of a randomized trial testing sequencing of chemotherapy and radiation therapy following conservative surgery for patients with early-stage breast cancer. N Engl J Med. 1996; 334:1356-61.1996-01-01T00:00:001996Five-year results of a randomized trial testing sequencing of chemotherapy and radiation therapy following conservative surgery for patients with early-stage breast cancerShulman LN.Schiffman FJ, ed. Hematolgoic pathophysiology.Hematologic malignancies. Schiffman FJ, ed. Hematolgoic pathophysiology. 1998; 291-317.1998-01-01T00:00:001998Hematologic malignancies7544029Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJSeminars in oncologyA phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Semin Oncol. 1995 Aug; 22(4 Suppl 9):70-4.Semin Oncol1995-08-01T00:00:001995A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.8293394Ballen KK, Gilliland DG, Kalish LA, Shulman LNCancerBone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival. Cancer. 1994 Jan 15; 73(2):314-21.Cancer1994-01-15T00:00:001994Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival.3942045Shulman L, Berwick DM, Caufield EA, Knapp MLAmerican family physicianDetection of colorectal cancer. Am Fam Physician. 1986 Jan; 33(1):177-81.Am Fam Physician1986-01-01T00:00:001986Detection of colorectal cancer.18200900Weingart SN, Cleary A, Seger A, Eng TK, Saadeh M, Gross A, Shulman LNJoint Commission journal on quality and patient safetyMedication reconciliation in ambulatory oncology. Jt Comm J Qual Patient Saf. 2007 Dec; 33(12):750-7.Jt Comm J Qual Patient Saf2007-12-01T00:00:002007Medication reconciliation in ambulatory oncology.9427731Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler CBloodPrimary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation. Blood. 1998 Jan 15; 91(2):717-23.Blood1998-01-15T00:00:001998Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.22415847Peppercorn J, Shapira I, Deshields T, Kroetz D, Friedman P, Spears P, Collyar DE, Shulman LN, Dressler L, Bertagnolli MMCancerEthical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience. Cancer. 2012 Oct 15; 118(20):5060-8.Cancer2012-03-13T00:00:002012Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience.21376593Harford JB, Otero IV, Anderson BO, Cazap E, Gradishar WJ, Gralow JR, Kane GM, Niëns LM, Porter PL, Reeler AV, Rieger PT, Shockney LD, Shulman LN, Soldak T, Thomas DB, Thompson B, Winchester DP, Zelle SG, Badwe RABreast (Edinburgh, Scotland)Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative. Breast. 2011 Apr; 20 Suppl 2:S20-9.Breast2011-03-04T00:00:002011Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.Authorship 10005745Authorship 10009176Authorship 10061399Authorship 100172211Authorship 100556214Authorship 1001643228717692Tapela N, Nzayisenga I, Sethi R, Bigirimana JB, Habineza H, Hategekimana V, Mantini N, Mpunga T, Shulman LN, Lehmann LJournal of global oncologyTreatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes. J Glob Oncol. 2016 Jun; 2(3):129-137.J Glob Oncol2016-02-03T00:00:002016Treatment of Chronic Myeloid Leukemia in Rural Rwanda: Promising Early Outcomes.28717689Shyirambere C, Xu MJ, Elmore SN, Fadelu T, May L, Tapela N, Umuhizi DG, Uwizeye FR, Driscoll C, Muhayimana C, Hategekimana V, Rubagumya F, Nzayisenga I, Shulman LN, Mpunga T, Lehmann LEJournal of global oncologyTreating Nephroblastoma in Rwanda: Using International Society of Pediatric Oncology Guidelines in a Novel Oncologic Care Model. J Glob Oncol. 2016 Jun; 2(3):105-113.J Glob Oncol2016-01-27T00:00:002016Treating Nephroblastoma in Rwanda: Using International Society of Pediatric Oncology Guidelines in a Novel Oncologic Care Model.6546621Sagar AD, Sehgal PB, May LT, Inouye M, Slate DL, Shulman L, Ruddle FHScience (New York, N.Y.)Interferon-beta-related DNA is dispersed in the human genome. Science. 1984 Mar 23; 223(4642):1312-5.Science1984-03-23T00:00:001984Interferon-beta-related DNA is dispersed in the human genome.3860969Sagar AD, Sehgal PB, May LT, Slate DL, Shulman L, Barker PE, Ruddle FHSomatic cell and molecular geneticsInterferon-beta-related DNA on human chromosome 4. Somat Cell Mol Genet. 1985 Jul; 11(4):403-8.Somat Cell Mol Genet1985-07-01T00:00:001985Interferon-beta-related DNA on human chromosome 4.28766360Sharma R, Shulman LN, James TAmerican journal of medical quality : the official journal of the American College of Medical QualityThe Future of Quality Improvement in Breast Cancer: Patient-Reported Outcomes. Am J Med Qual. 2017 Sep/Oct; 32(5):469-471.Am J Med Qual2017-08-02T00:00:002017The Future of Quality Improvement in Breast Cancer: Patient-Reported Outcomes.28717686Mpunga T, Hedt-Gauthier BL, Tapela N, Nshimiyimana I, Muvugabigwi G, Pritchett N, Greenberg L, Benewe O, Shulman DS, Pepoon JR, Shulman LN, Milner DAJournal of global oncologyImplementation and Validation of Telepathology Triage at Cancer Referral Center in Rural Rwanda. J Glob Oncol. 2016 Apr; 2(2):76-82.J Glob Oncol2016-01-20T00:00:002016Implementation and Validation of Telepathology Triage at Cancer Referral Center in Rural Rwanda.19817031Ettinger DS, Arnoletti JP, Gockerman JP, Handorf C, Havlin KA, Jacobs CD, Javle M, Kvols L, Lenzi R, Rashid A, Rhoades CA, Ridge JA, Saltz L, Shulman LN, Sondak VK, Thompson JA, Twardowski P, Zhen WJournal of the National Comprehensive Cancer Network : JNCCNOccult primary cancer clinical practice guidelines. J Natl Compr Canc Netw. 2005 Mar; 3(2):214-33.J Natl Compr Canc Netw2005-03-01T00:00:002005Occult primary cancer clinical practice guidelines.Shulman LN.Brigham and Women's Hospital: Medical UpdateAdjuvant therapy of colorectal cancer. Brigham and Women's Hospital: Medical Update. 1991; 3:1-5.1991-01-01T00:00:001991Adjuvant therapy of colorectal cancer6860589Shulman LN, Robinson SHBritish journal of haematologyTransition from granulocyte to macrophage predominance in bone marrow cultures. Br J Haematol. 1983 Jul; 54(3):405-14.Br J Haematol1983-07-01T00:00:001983Transition from granulocyte to macrophage predominance in bone marrow cultures.8113842Lynch TJ, Kalish L, Strauss G, Elias A, Skarin A, Shulman LN, Posner M, Frei EJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.J Clin Oncol1994-02-01T00:00:001994Phase II study of topotecan in metastatic non-small-cell lung cancer.10477008Hardenbergh PH, Recht A, Gollamudi S, Come SE, Hayes DF, Shulman LN, O'Neill A, Gelman RS, Silver B, Harris JRInternational journal of radiation oncology, biology, physicsTreatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer. Int J Radiat Oncol Biol Phys. 1999 Aug 01; 45(1):69-72.Int J Radiat Oncol Biol Phys1999-08-01T00:00:001999Treatment-related toxicity from a randomized trial of the sequencing of doxorubicin and radiation therapy in patients treated for early stage breast cancer.15596916McCollum AD, Kulke MH, Ryan DP, Clark JW, Shulman LN, Mayer RJ, Bartel S, Fuchs CSAmerican journal of clinical oncologyLack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors. Am J Clin Oncol. 2004 Oct; 27(5):485-8.Am J Clin Oncol2004-10-01T00:00:002004Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.2754448Leopold KA, Canellos GP, Rosenthal D, Shulman LN, Weinstein H, Mauch PJournal of clinical oncology : official journal of the American Society of Clinical OncologyStage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy. J Clin Oncol. 1989 Aug; 7(8):1059-65.J Clin Oncol1989-08-01T00:00:001989Stage IA-IIB Hodgkin's disease: staging and treatment of patients with large mediastinal adenopathy.21253541Shulman LN, Willett W, Sievers A, Knaul FMJournal of oncologyBreast cancer in developing countries: opportunities for improved survival. J Oncol. 2010; 2010:595167.J Oncol2010-12-29T00:00:002010Breast cancer in developing countries: opportunities for improved survival.21646556Keating NL, Landrum MB, Lamont EB, Bozeman SR, Krasnow SH, Shulman LN, Brown JR, Earle CC, Oh WK, Rabin M, McNeil BJAnnals of internal medicineQuality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study. Ann Intern Med. 2011 Jun 07; 154(11):727-36.Ann Intern Med2011-06-07T00:00:002011Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study.28759361Rubagumya F, Greenberg L, Manirakiza A, DeBoer R, Park PH, Mpunga T, Shulman LNThe Lancet. OncologyIncreasing global access to cancer care: models of care with non-oncologists as primary providers. Lancet Oncol. 2017 08; 18(8):1000-1002.Lancet Oncol2017-07-26T00:00:002017Increasing global access to cancer care: models of care with non-oncologists as primary providers.Bellon JR, Shulman LN.Am J Oncol Rev Breast-conserving surgery vs mastectomy: How much data do we need to gain widespread acceptance and utilization? (commentary). Am J Oncol Rev. 2003; 2:42-4.2003-01-01T00:00:002003Breast-conserving surgery vs mastectomy: How much data do we need to gain widespread acceptance and utilization? (commentary)Shulman LN.Brigham and Women's Hospital: Medical UpdatePrimary breast cancer with negative axillary nodes: prognosis and therapy. Brigham and Women's Hospital: Medical Update. 1992; 4:1-5.1992-01-01T00:00:001992Primary breast cancer with negative axillary nodes: prognosis and therapy7088959Shulman LN, Robinson SHProceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)Origin of multinucleated giant cells in long-term diffusion chamber cultures. Proc Soc Exp Biol Med. 1982 Jul; 170(3):359-62.Proc Soc Exp Biol Med1982-07-01T00:00:001982Origin of multinucleated giant cells in long-term diffusion chamber cultures.8468267Shulman LNHematology/oncology clinics of North AmericaThe biology of alkylating-agent cellular injury. Hematol Oncol Clin North Am. 1993 Apr; 7(2):325-35.Hematol Oncol Clin North Am1993-04-01T00:00:001993The biology of alkylating-agent cellular injury.8686620Shaffer K, Smith D, Kirn D, Kaplan W, Canellos G, Mauch P, Shulman LNAJR. American journal of roentgenologyPrimary mediastinal large-B-cell lymphoma: radiologic findings at presentation. AJR Am J Roentgenol. 1996 Aug; 167(2):425-30.AJR Am J Roentgenol1996-08-01T00:00:001996Primary mediastinal large-B-cell lymphoma: radiologic findings at presentation.1830248Teicher BA, Herman TS, Shulman L, Bubley G, Coleman CN, Frei ECancer chemotherapy and pharmacologyCombination of etanidazole with cyclophosphamide and platinum complexes. Cancer Chemother Pharmacol. 1991; 28(3):153-8.Cancer Chemother Pharmacol1991-01-01T00:00:001991Combination of etanidazole with cyclophosphamide and platinum complexes.15774786Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht AJournal of clinical oncology : official journal of the American Society of Clinical OncologySequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20; 23(9):1934-40.J Clin Oncol2005-03-20T00:00:002005Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial.18678836Goldstein LJ, O'Neill A, Sparano JA, Perez EA, Shulman LN, Martino S, Davidson NEJournal of clinical oncology : official journal of the American Society of Clinical OncologyConcurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197. J Clin Oncol. 2008 Sep 01; 26(25):4092-9.J Clin Oncol2008-08-04T00:00:002008Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.450 Brookline AveDana-Farber Cancer InstituteMedcn450 Brookline AveBoston02215MA22157556Ettinger DS, Agulnik M, Cates JM, Cristea M, Denlinger CS, Eaton KD, Fidias PM, Gierada D, Gockerman JP, Handorf CR, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Shulman LN, Smerage JB, Varadhachary GR, Zager JS, Zhen WKJournal of the National Comprehensive Cancer Network : JNCCNNCCN Clinical Practice Guidelines Occult primary. J Natl Compr Canc Netw. 2011 Dec; 9(12):1358-95.J Natl Compr Canc Netw2011-12-01T00:00:002011NCCN Clinical Practice Guidelines Occult primary.Authorship 1024012129091535Shulman LN, Palis BE, McCabe R, Mallin K, Loomis A, Winchester D, McKellar DJournal of oncology practiceSurvival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance. J Oncol Pract. 2018 01; 14(1):e59-e72.J Oncol Pract2017-11-01T00:00:002017Survival As a Quality Metric of Cancer Care: Use of the National Cancer Data Base to Assess Hospital Performance.Shulman LN.Am J Oncol RevNeoadjuvant chemotherapy followed by mastectomy: Who need radiation? (commentary). Am J Oncol Rev. 2002; 1:20-1.2002-01-01T00:00:002002Neoadjuvant chemotherapy followed by mastectomy: Who need radiation? (commentary)Shulman LN.Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and practice of hematology.Plasma cell diseases and related disorders. Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and practice of hematology. 1995; 885-913.1995-01-01T00:00:001995Plasma cell diseases and related disorders10690396Miller KD, Picus J, Blanke C, John W, Clark J, Shulman LN, Thornton D, Rowinsky E, Loehrer PJAnnals of oncology : official journal of the European Society for Medical OncologyPhase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer. Ann Oncol. 2000 Jan; 11(1):101-3.Ann Oncol2000-01-01T00:00:002000Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.10715290Burstein HJ, Manola J, Younger J, Parker LM, Bunnell CA, Scheib R, Matulonis UA, Garber JE, Clarke KD, Shulman LN, Winer EPJournal of clinical oncology : official journal of the American Society of Clinical OncologyDocetaxel administered on a weekly basis for metastatic breast cancer. J Clin Oncol. 2000 Mar; 18(6):1212-9.J Clin Oncol2000-03-01T00:00:002000Docetaxel administered on a weekly basis for metastatic breast cancer.7685241Uematsu M, Tarbell NJ, Silver B, Coleman CN, Rosenthal DS, Shulman LN, Canellos G, Weinstein H, Mauch PCancerWide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy. Cancer. 1993 Jul 01; 72(1):207-12.Cancer1993-07-01T00:00:001993Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.12584460Ponte PR, Conlin G, Conway JB, Grant S, Medeiros C, Nies J, Shulman L, Branowicki P, Conley KThe Journal of nursing administrationMaking patient-centered care come alive: achieving full integration of the patient's perspective. J Nurs Adm. 2003 Feb; 33(2):82-90.J Nurs Adm2003-02-01T00:00:002003Making patient-centered care come alive: achieving full integration of the patient's perspective.22235542Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SNJoint Commission journal on quality and patient safetyIdentifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 2011 Dec; 37(12):568-75.Jt Comm J Qual Patient Saf2011-12-01T00:00:002011Identifying women at risk of delayed breast cancer diagnosis.8195037Doherty N, Hancock SL, Kaye S, Coleman CN, Shulman L, Marquez C, Mariscal C, Rampling R, Senan S, Roemeling RVInternational journal of radiation oncology, biology, physicsMuscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation. Int J Radiat Oncol Biol Phys. 1994 May 15; 29(2):379-82.Int J Radiat Oncol Biol Phys1994-05-15T00:00:001994Muscle cramping in phase I clinical trials of tirapazamine (SR 4233) with and without radiation.17345004Lin NU, Parker LM, Come SE, Burstein HJ, Haldoupis M, Ryabin N, Gelman R, Winer EP, Shulman LNInvestigational new drugsPhase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions. Invest New Drugs. 2007 Aug; 25(4):369-75.Invest New Drugs2007-03-08T00:00:002007Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer: unexpected incidence of hypersensitivity reactions.19176200Ettinger DS, Agulnik M, Cristea M, Eaton K, Fidias PM, Gockerman JP, Hameed O, Handorf C, Harris EI, Jacobs CD, Javle M, Khushalani NI, Kvols L, Lenzi R, Lewis NL, Rashid A, Saltz L, Shulman LN, Zager JS, Zhen WJournal of the National Comprehensive Cancer Network : JNCCNOccult primary. J Natl Compr Canc Netw. 2008 Nov; 6(10):1026-60.J Natl Compr Canc Netw2008-11-01T00:00:002008Occult primary.3384712Shulman LN, Bunn HFHemoglobinHb Deer Lodge in a Caucasian American: effect of iron deficiency on level of variant. Hemoglobin. 1988; 12(2):197-9.Hemoglobin1988-01-01T00:00:001988Hb Deer Lodge in a Caucasian American: effect of iron deficiency on level of variant.7986706Tepler I, Elias A, Kalish L, Shulman L, Strauss G, Skarin A, Lynch T, Levitt D, Resta D, Demetri GBritish journal of haematologyEffect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression. Br J Haematol. 1994 Aug; 87(4):678-86.Br J Haematol1994-08-01T00:00:001994Effect of recombinant human interleukin-3 on haematological recovery from chemotherapy-induced myelosuppression.7989930Marcus KC, Kalish LA, Coleman CN, Shulman LN, Rosenthal DS, Canellos GP, Mauch PMJournal of clinical oncology : official journal of the American Society of Clinical OncologyImproved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. J Clin Oncol. 1994 Dec; 12(12):2567-72.J Clin Oncol1994-12-01T00:00:001994Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.8611686Mauch PM, Kalish LA, Marcus KC, Coleman CN, Shulman LN, Krill E, Come S, Silver B, Canellos GP, Tarbell NJBloodSecond malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32.Blood1996-05-01T00:00:001996Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.18656009Bansal A, Binkert CA, Robinson MK, Shulman LN, Pellerin L, Davison BJournal of vascular and interventional radiology : JVIRImpact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting. J Vasc Interv Radiol. 2008 Aug; 19(8):1171-5.J Vasc Interv Radiol2008-06-17T00:00:002008Impact of quality management monitoring and intervention on central venous catheter dysfunction in the outpatient chemotherapy infusion setting.18678838Goldstein LJ, Gray R, Badve S, Childs BH, Yoshizawa C, Rowley S, Shak S, Baehner FL, Ravdin PM, Davidson NE, Sledge GW, Perez EA, Shulman LN, Martino S, Sparano JAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPrognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol. 2008 Sep 01; 26(25):4063-71.J Clin Oncol2008-08-04T00:00:002008Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features.21886491Neuss MN, Flamm C, Shulman LN, Tomkins JE, Ward JCJournal of oncology practiceReport on the ASCO 2010 Provider-Payer Initiative Meeting. J Oncol Pract. 2011 May; 7(3):136-40.J Oncol Pract2011-05-01T00:00:002011Report on the ASCO 2010 Provider-Payer Initiative Meeting.18234756Shulman LN, Hitt RA, Ferry JAThe New England journal of medicineCase records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left breast and shortness of breath. N Engl J Med. 2008 Jan 31; 358(5):513-23.N Engl J Med2008-01-31T00:00:002008Case records of the Massachusetts General Hospital. Case 4-2008. A 33-year-old pregnant woman with swelling of the left breast and shortness of breath.Shulman LN. Irwin RS, Cerra FB, Rippe JM, eds. Irwin and Rippe's Intensive care medicineThe acute leukemias. Irwin RS, Cerra FB, Rippe JM, eds. Irwin and Rippe's Intensive care medicine. 1999; 1391-5.1999-01-01T00:00:001999The acute leukemiasShulman LN.Robinson SH, Reich PR, eds. Hematology: Pathophysiologic basis for clinical practice.Normocytic anemias. Robinson SH, Reich PR, eds. Hematology: Pathophysiologic basis for clinical practice. 1993; 109-26.1993-01-01T00:00:001993Normocytic anemiasHassett MJ, Shulman LN.Am J Oncol RevA tale of two taxanes: Docetaxel or paclitaxel for advanced or metastatic breast cancer. Am J Oncol Rev. 2006; 5:162-4.2006-01-01T00:00:002006A tale of two taxanes: Docetaxel or paclitaxel for advanced or metastatic breast cancer7658540Comiter CV, Benson CJ, Capelouto CC, Kantoff P, Shulman L, Richie JP, Loughlin KRThe Journal of urologyNonpalpable intratesticular masses detected sonographically. J Urol. 1995 Oct; 154(4):1367-9.J Urol1995-10-01T00:00:001995Nonpalpable intratesticular masses detected sonographically.8453585Healey EA, Tarbell NJ, Kalish LA, Silver B, Rosenthal DS, Marcus K, Shulman LN, Coleman CN, Canellos G, Weinstein HCancerPrognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20.Cancer1993-04-15T00:00:001993Prognostic factors for patients with Hodgkin disease in first relapse.Shulman LN.Carlson K, Eisenstat SA, eds. The primary care of women.Non-gynecologic cancer. Carlson K, Eisenstat SA, eds. The primary care of women. 1995; 368-73.1995-01-01T00:00:001995Non-gynecologic cancer20709386Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, Atun R, Blayney D, Chen L, Feachem R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M, Seffrin JRLancet (London, England)Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet. 2010 Oct 02; 376(9747):1186-93.Lancet2010-08-13T00:00:002010Expansion of cancer care and control in countries of low and middle income: a call to action.21294481Bunnell CA, Shulman LNOncology (Williston Park, N.Y.)Will we be able to care for cancer patients in the future? Oncology (Williston Park). 2010 Dec; 24(14):1343-8.Oncology (Williston Park)2010-12-01T00:00:002010Will we be able to care for cancer patients in the future?Authorship 1042273722956949Sharma K, Costas A, Shulman LN, Meara JGJournal of oncologyA systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol. 2012; 2012:121873.J Oncol2012-08-22T00:00:002012A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation.Lee SJ, Shulman LN.Rakel RE ed. Conn's current therapy.Acute leukemia in adults. Rakel RE ed. Conn's current therapy. 1995; 359-64.1995-01-01T00:00:001995Acute leukemia in adultsAuthorship 10556239874455Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JLCancerCorrelation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998 Dec 15; 83(12):2502-8.Cancer1998-12-15T00:00:001998Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.11222787Shoulson I, Penney J, McDermott M, Schwid S, Kayson E, Chase T, Fahn S, Greenamyre JT, Lang A, Siderowf A, Pearson N, Harrison M, Rost E, Colcher A, Lloyd M, Matthews M, Pahwa R, McGuire D, Lew MF, Schuman S, Marek K, Broshjeit S, Factor S, Brown D, Feigin A, Mazurkiewicz J, Ford B, Jennings D, Dilllon S, Comella C, Blasucci L, Janko K, Shulman L, Wiener W, Bateman-Rodriguez D, Carrion A, Suchowersky O, Lafontaine AL, Pantella C, Siemers E, Belden J, Davies R, Lannon M, Grimes D, Gray P, Martin W, Kennedy L, Adler C, Newman S, Hammerstad J, Stone C, Lewitt P, Bardram K, Mistura K, Miyasaki J, Johnston L, Cha JH, Tennis M, Panniset M, Hall J, Tetrud J, Friedlander J, Hauser R, Gauger L, Rodnitzky R, Deleo A, Dobson J, Seeberger L, Dingmann C, Tarsy D, Ryan P, Elmer L, Ruzicka D, Stacy M, Brewer M, Locke B, Baker D, Casaceli C, Day D, Florack M, Hodgeman K, Laroia N, Nobel R, Orme C, Rexo L, Rothenburgh K, Sulimowicz K, Watts A, Wratni E, Tariot P, Cox C, Leventhal C, Alderfer V, Craun AM, Frey J, McCree L, McDermott J, Cooper J, Holdich T, Read BNeurologyA randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease. Neurology. 2001 Feb 27; 56(4):455-62.Neurology2001-02-27T00:00:002001A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease.11761451Bunnell CA, Supko JG, Eder JP, Clark JW, Lynch TJ, Kufe DW, Shulman LNCancer chemotherapy and pharmacologyPhase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies. Cancer Chemother Pharmacol. 2001 Nov; 48(5):347-55.Cancer Chemother Pharmacol2001-11-01T00:00:002001Phase I clinical trial of 7-cyanoquinocarcinol (DX-52-1) in adult patients with refractory solid malignancies.10114296Kaye JA, Shulman LNHMO practiceScreening program for colorectal cancer: participation and follow up. HMO Pract. 1991 Sep-Oct; 5(5):168-70.HMO Pract1991-09-01T00:00:001991Screening program for colorectal cancer: participation and follow up.Mentzer SJ, Sugarbaker DJ, Shulman LN.Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast.Management of Discrete Pulmonary Nodules. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2004; 1273-8.2004-01-01T00:00:002004Management of Discrete Pulmonary Nodules23277761Gatzos LC, Barbetti S, Bas-Davis S, Mailman A, Brzezinski P, Ruseau P, Barr Vermilya H, Schott D, Marston E, Sturtevant OJ, Ritz J, Shulman LNJournal of oncology practiceDevelopment and implementation of a computerized system for collection, processing, and administration of cellular therapy products. J Oncol Pract. 2012 Sep; 8(5):262-6.J Oncol Pract2012-05-15T00:00:002012Development and implementation of a computerized system for collection, processing, and administration of cellular therapy products.Gore SM, Shulman LN, Osteen RT.Osteen RT, ed. Cancer ManualMetastatic cancer from an unknown primary site. Osteen RT, ed. Cancer Manual. 1996; 596-607.1996-01-01T00:00:001996Metastatic cancer from an unknown primary siteShulman LN, Sugarbaker DJ.Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast.Malignant effusions. Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the breast. 2000; 893-900.2000-01-01T00:00:002000Malignant effusions1530197Eng C, Farraye FA, Shulman LN, Peppercorn MA, Krauss CM, Connors JM, Stone RMAnnals of internal medicineThe association between the myelodysplastic syndromes and Crohn disease. Ann Intern Med. 1992 Oct 15; 117(8):661-2.Ann Intern Med1992-10-15T00:00:001992The association between the myelodysplastic syndromes and Crohn disease.Shulman LN.Rippe JM, Irwin RS, Alpert JS, Fink MP, eds. Intensive care medicine. The acute leukemias. Rippe JM, Irwin RS, Alpert JS, Fink MP, eds. Intensive care medicine. 1991; 1070-5.1991-01-01T00:00:001991The acute leukemias9166452Mauch PM, Kalish LA, Marcus KC, Shulman LN, Krill E, Tarbell NJ, Silver B, Weinstein H, Come S, Canellos GP, Coleman CNThe cancer journal from Scientific AmericanLong-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42.Cancer J Sci Am1995-05-01T00:00:001995Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.